<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="./PMC1074505/results/search/medproc/results.xml">
   <result pre="one-third of all the SARS patients required high flow oxygen" exact="therapy" post="4, 20–30% required intensive care unit (ICU) admission or"/>
   <result pre="liver, and kidneys 22. 3. Pharmacological Therapy General principles Anti-bacterial" exact="therapy" post="for community-acquired pneumonia in accordance with standard guidelines 23"/>
   <result pre="administered before laboratory confirmation of SARS-CoV infection. Where effective anti-viral" exact="therapy" post="is available, it should be started as early as"/>
   <result pre="to the immunopathological phase 5, concomitant institution of an immunomodulatory" exact="therapy" post="should also be considered 11. Since there are no"/>
   <result pre="assisted ventilation and intensive supportive treatments will be required. Antiviral" exact="therapy" post="Ribavirin was the most commonly used empirical antiviral agent"/>
   <result pre="Kong 26, 31 patients who had received Kaletra as rescue" exact="therapy" post="together with high dose corticosteroids had no difference in"/>
   <result pre="Baicalin, also demonstrates anti-SARS-CoV activity in vitro (unpublished data). Immunomodulatory" exact="therapy" post="In the absence of an effective antiviral agent in"/>
   <result pre="could sometimes occur very rapidly; immediate administration of pulsed methylprednisolone" exact="therapy" post="at 500–1000 mg per day intravenously for 2 days,"/>
   <result pre="12 patients who deteriorated despite repeated rescue methylprednisolone and ribavirin" exact="therapy" post="had shown some improvement in radiographic scores and oxygen"/>
   <result pre="12890854 52 Van den Berghe G et al. Intensive insulin" exact="therapy" post="in critically ill patients N Engl J Med 2001"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2532878/results/search/medproc/results.xml">
   <result pre="vaccines and any other vaccines indicated by their health status." exact="Immunization" post="records should be maintained for all personnel ( 2)."/>
   <result pre="26, 2008) 57 collab: Canadian Paediatric Society, Infectious Diseases and" exact="Immunization" post="Committee [Principal author: D Moore] Control and treatment of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2600302/results/search/medproc/results.xml">
   <result pre="difficult for viruses requiring BSL-4 precautions that lack any licensed" exact="therapy" post="or prophylaxis. Therefore, having access to subject matter experts"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2600382/results/search/medproc/results.xml">
   <result pre="References References 1. collab: Centers for Disease Control and Prevention" exact="Immunization" post="of health-care workers: recommendations of the Advisory Committee on"/>
   <result pre="Immunization of health-care workers: recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP) and the Hospital Infection Control Practices Advisory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2662657/results/search/medproc/results.xml">
   <result pre="GV Patient knows best: blinded assessment of nonadherence with antituberculous" exact="therapy" post="by physicians, nurses, and patients compared with urine drug"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2700590/results/search/medproc/results.xml">
   <result pre="data can detect an influenza-like illness in a particular area." exact="Vaccination" post="strategy There are vaccines which can prevent swine influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2727517/results/search/medproc/results.xml">
   <result pre="X ray, diabetes mellitus, HIV infection or having received immunosuppressive" exact="therapy" post="or steroids. These factors may contribute to a false"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2749164/results/search/medproc/results.xml">
   <result pre="severe acute respiratory syndrome admitted to a ward required oxygen" exact="therapy" post="(4.30, 1.00 to 18.43), and whether any index patients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2763061/results/search/medproc/results.xml">
   <result pre="exhibited an uncomplicated illness of limited duration. Hospitalization or antiviral" exact="therapy" post="is therefore not likely to be required for most"/>
   <result pre="usually acute tubular necrosis, and in such cases renal replacement" exact="therapy" post="may be needed. 5.2.4 Corticosteroids: controversy exists as to"/>
   <result pre="about prioritizing treatment within groups at higher risk. 53 Antiviral" exact="therapy" post="may be beneficial, especially for the following groups: 54"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2818714/results/search/medproc/results.xml">
   <result pre="antivirals may be ineffective in combating the spread of infection." exact="Vaccination" post="is typically the first line of defense against influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2819791/results/search/medproc/results.xml">
   <result pre="were closed during the whole day 13:50 1,071 A body" exact="therapy" post="was performed and there were 3 persons in the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2851524/results/search/medproc/results.xml">
   <result pre="gowns, N95 masks, gloves, and eye protection) and antiviral drug" exact="therapy" post="will be necessary for an unpredictable period. With awareness"/>
   <result pre="multicenter study to estimate the quantity of PPE and antiviral" exact="therapy" post="that may be required to manage patients with suspected"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2859468/results/search/medproc/results.xml">
   <result pre="reporting use at all times. Seasonal influenza illness and vaccination" exact="Vaccination" post="in the 2007–2008 season was not statistically associated with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2873403/results/search/medproc/results.xml">
   <result pre="d 15(39%) 4(57%) 0.43 b 19 (42%) Patient Characteristics at" exact="Intubation" post="Day of illness at time of intubation a 9(7,"/>
   <result pre="intubation 33 (87%) 6(86%) 0.99 b 39 (87%) Characteristics of" exact="Intubation" post="Intubation difficult 12(32%) 3(43%) 0.67 b 15(33%) Intubation performed"/>
   <result pre="33 (87%) 6(86%) 0.99 b 39 (87%) Characteristics of Intubation" exact="Intubation" post="difficult 12(32%) 3(43%) 0.67 b 15(33%) Intubation performed during"/>
   <result pre="Characteristics of Intubation Intubation difficult 12(32%) 3(43%) 0.67 b 15(33%)" exact="Intubation" post="performed during night shift 7(18%) 1(14%) 0.99 b 8(18%)"/>
   <result pre="b 8(18%) Primary intubator experienced 32(84%) 6(86%) 0.99 b 38(84%)" exact="Intubation" post="emergent 0(0%) 1(14%) 0.16 b 1(2%) Patient Outcome Deceased"/>
   <result pre="9 (35%) .73 236 (38%) HCW involvement in intubation a" exact="Intubation" post="(including fiber optic intubation) 132 (22%) 12 (46%) &amp;lt;0.01"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2921383/results/search/medproc/results.xml">
   <result pre="Menasalvas A Ramírez C Guerrero C The Effect of BCG" exact="Vaccination" post="on Tuberculin Reactivity and the Booster Effect Among Hospital"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC2999721/results/search/medproc/results.xml">
   <result pre="chest CT and had signs of incipient interstitial fibrosis, pulse" exact="therapy" post="with methylprednisolone (1 g/day) for three consecutive days was"/>
   <result pre="the virus, collection of respiratory specimens for RT‐PCR, and immediate" exact="therapy" post="with oseltamivir. It is noteworthy that the rapid test"/>
   <result pre="in the prone position can be used as a rescue" exact="therapy" post="for patients with refractory hypoxemia. 7 Prone positioning leads"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3017695/results/search/medproc/results.xml">
   <result pre="674 (76.6%) of hospital employees and 631 (65.9%) of outpatients." exact="Vaccination" post="was desired by 479 (54.4%) of hospital employees and"/>
   <result pre="not occurred in the UK before that study. 2, 3" exact="Vaccination" post="for pandemic influenza was not an option during the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3033073/results/search/medproc/results.xml">
   <result pre="in Singapore in March 2003. To illustrate the problems in" exact="diagnosing" post="and containing SARS in the hospital, we describe a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3071337/results/search/medproc/results.xml">
   <result pre="Van Dort M Rehemtulla A Ross BD Targeted imaging and" exact="therapy" post="of brain cancer using theranostic nanoparticles Mol Pharm 2010"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3096589/results/search/medproc/results.xml">
   <result pre="the patient, some were prepared to refer for directly observed" exact="therapy" post="short course (DOTS) treatment support because &quot;... they are"/>
   <result pre="role of traditional medicine. Only traditional healers trained in TB" exact="therapy" post="support were acceptable to some participants. Although there is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3168221/results/search/medproc/results.xml">
   <result pre="of scarce medical resources. Influenza H1N1 swine flu vaccination anti-viral" exact="therapy" post="pandemic response When a new H1N1 strain of influenza"/>
   <result pre="people admitted to ICU, there were considerable delays in both" exact="diagnosing" post="their infection and receiving appropriate therapy. The value of"/>
   <result pre="9 days ( 5)—before those with recognised risk factors received" exact="therapy" post="after the onset of their symptoms. The widespread media"/>
   <result pre="A Jit M Stefan Flaschea S White PJ Edmunds WJ" exact="Vaccination" post="against pandemic influenza A/H1N1v in England: A real-time economic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3214442/results/search/medproc/results.xml">
   <result pre="being performed. Throat swab examination is the correct method for" exact="diagnosing" post="swine flu infection, correctly known to majority of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3228724/results/search/medproc/results.xml">
   <result pre="was given on an ambulatory basis and under directly observed" exact="therapy" post="using a decentralized network of providers. Patients not already"/>
   <result pre="often inconsistently reported [9], [10]. Although the use of antiretroviral" exact="therapy" post="(ART) with MDR-TB treatment has been shown to improve"/>
   <result pre="to promptly diagnose and appropriately manage adverse drug effects. Third," exact="therapy" post="followed internationally recommended guidelines with maximally effective drug combinations,"/>
   <result pre="rates remain largely unreported [28], [29]. Similarly, failure to initiate" exact="therapy" post="and default from treatment rates were high in this"/>
   <result pre="mortality of HIV/MDR-TB co-infected patients. Rapid scale-up of both antiretroviral" exact="therapy" post="and second line treatment for MDR-TB is needed to"/>
   <result pre="e7186 19779624 14 collab: World Health Organization (WHO) 2010 Antiretroviral" exact="therapy" post="for HIV infection in adults and adolescents. Recommendations for"/>
   <result pre="Palacios E Shin S Furin J et al. 2003 Community-based" exact="therapy" post="for multidrug-resistant tuberculosis in Lima, Peru. N Engl J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3266527/results/search/medproc/results.xml">
   <result pre="active exercises at home. Physical activity may be beneficial. Biofeedback" exact="therapy" post="has a documented effect on migraine [ 8]. Behavioural"/>
   <result pre="therapy has a documented effect on migraine [ 8]. Behavioural" exact="therapy" post="and cognitive therapy (stress and pain management) are probably"/>
   <result pre="documented effect on migraine [ 8]. Behavioural therapy and cognitive" exact="therapy" post="(stress and pain management) are probably effective, but offered"/>
   <result pre="such measures have an effect [ 26]. Behavioural and cognitive" exact="therapy" post="(stress and pain management) is typically performed by psychologists."/>
   <result pre="alone has a documented effect on tension-type headache [ 8]." exact="Acupuncture" post="is a frequently used measure. Controlled trials of the"/>
   <result pre="719 28. Melchart D Streng A Hoppe A et al." exact="Acupuncture" post="in patients with tension-type headache: randomised controlled trial BMJ"/>
   <result pre="Aegidius KL Zwart JA Hagen K Schei B Stovner LJ" exact="Hormone replacement therapy" post="and headache prevalence in postmenopausal women. The Head-HUNT study"/>
   <result pre="Zwart JA Hagen K Schei B Stovner LJ Hormone replacement" exact="therapy" post="and headache prevalence in postmenopausal women. The Head-HUNT study"/>
   <result pre="Bruijn JK Verhagen AP Berger MY Passchier J Koes BW" exact="Symptomatic treatment" post="of migraine in children: a systematic review of medication"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3270909/results/search/medproc/results.xml">
   <result pre="population mental health as well as commercial and economic resilience." exact="Vaccination" post="has been identified in the Australian plan and by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3285078/results/search/medproc/results.xml">
   <result pre="evaluation independent of study procedures. By definition, a &quot;timely&quot; antiviral" exact="therapy" post="started within 2 days of symptom onset. When household"/>
   <result pre="influenced household transmission of influenza (i.e. age, sex, timely antiviral" exact="therapy" post="of the index, vaccination of household contacts, etc.) adjusted"/>
   <result pre="2009/10 - the number of index patients receiving timely antiviral" exact="therapy" post="was significantly higher in 2010/11 ( p &amp;lt; 0.001)."/>
   <result pre="8/38 (21) 3/28 (11) IQR Inter-Quartile-Range, SD Standard deviation. *" exact="Vaccination" post="defined as vaccination against pandemic influenza in the pandemic"/>
   <result pre="14 days before symptom onset in index patient. ** Antiviral" exact="therapy" post="defined as treatment with oseltamivir or zanamivir within 2"/>
   <result pre="(such as sex, age, time spent at home, timely antiviral" exact="therapy" post="of the index patient, and vaccination of the household"/>
   <result pre="0.01 3.98 1.34-11.77 0.01 Therapy of Index patient*  No timely" exact="therapy" post="Ref. Ref.  Timely therapy 1.63 0.70-3.81 0.26 1.07 0.42-2.7"/>
   <result pre="Therapy of Index patient*  No timely therapy Ref. Ref.  Timely" exact="therapy" post="1.63 0.70-3.81 0.26 1.07 0.42-2.7 0.89 Vaccination of Contact*"/>
   <result pre="Ref. Ref.  Timely therapy 1.63 0.70-3.81 0.26 1.07 0.42-2.7 0.89" exact="Vaccination" post="of Contact*  No vaccination Ref. Ref.  Vaccination 0.62 0.11-3.56"/>
   <result pre="influence household transmission of influenza (i.e. age, sex, timely antiviral" exact="therapy" post="of the index, vaccination of household contacts) adjusted for"/>
   <result pre="CI 95% Confidence Interval. * adjusted for age, sex, timely" exact="therapy" post="of the index, vaccination of household contacts, time spent"/>
   <result pre="time spent at home. ** adjusted for age, sex, timely" exact="therapy" post="of the index, time spent at home. *** adjusted"/>
   <result pre="CI 95% Confidence Interval. * adjusted for age, sex, timely" exact="therapy" post="of the index, vaccination of household contacts, time spent"/>
   <result pre="time spent at home. ** adjusted for age, sex, timely" exact="therapy" post="of the index, time spent at home Behaviour and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3294397/results/search/medproc/results.xml">
   <result pre="as operating theater, radiology, laboratory medicine, pharmacy, physiotherapy, and occupational" exact="therapy" post="departments. Included in these were 3 postulated high-exposure settings:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3298234/results/search/medproc/results.xml">
   <result pre="Eisei. 2003; 67: 826– 30 13. Nakashima H Prevention and" exact="therapy" post="for SARS virus infection [article in Japanese] Bio Clinica."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3321963/results/search/medproc/results.xml">
   <result pre="Editor: Letter Pandemic (H1N1) 2009 Risk for Nurses after Trivalent" exact="Vaccination" post="Pandemic (H1N1) 2009 Risk for Nurses after Trivalent Vaccination"/>
   <result pre="Trivalent Vaccination Pandemic (H1N1) 2009 Risk for Nurses after Trivalent" exact="Vaccination" post="Loeb Mark Earn David J.D. Smieja Marek Webby Richard"/>
   <result pre="A total of 128 (30.3%) received the trivalent influenza vaccine." exact="Vaccination" post="status was similar between the groups: 68 (30.2%) persons"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3322896/results/search/medproc/results.xml">
   <result pre="to her antimicrobial regimen, and rifampin was initiated as adjuvant" exact="therapy" post="for possible legionellosis. Because the patient’s diagnosis remained elusive,"/>
   <result pre="348: 1967– 76 10.1056/NEJMoa030747 12690091 4. collab: Advisory Committee on" exact="Immunization" post="Practices Prevention and control of influenza. Recommendations of the"/>
   <result pre="and control of influenza. Recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP). MMWR Recomm Rep. 2003; 52( RR-8): 1–"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3322898/results/search/medproc/results.xml">
   <result pre="unexposed) (%) Relative risk (95% CI) p value Exposed Unexposed" exact="Intubation" post="3/4 (75) 5/28 (18) 4.20 (1.58 to 11.14) 0.04"/>
   <result pre="to 3.02) 1.00 Debrillation 0/2 (0) 8/ 30 (0.27) 1.00" exact="Cardiopulmonary resuscitation" post="0/3 (0) 8/29 (28) 0.55 Chest physiotherapy 2/7 (29)"/>
   <result pre="Intubation, suctioning before intubation 5 3 ICU 555 Gloves Gown N95 Goggles d" exact="Intubation" post="6 2 CCU 510 None 7 2 CCU 40"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3322918/results/search/medproc/results.xml">
   <result pre="[#], [**], [††], [1], Address for correspondence: Sharon Bloom, National" exact="Immunization" post="Program, Centers for Disease Control and Prevention, 1600 Clifton"/>
   <result pre="University. Dr. Bloom is a medical epidemiologist at the National" exact="Immunization" post="Program, Centers for Disease Control and Prevention. Dr. Bloom"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3410141/results/search/medproc/results.xml">
   <result pre="of novel vaccines and medicines for the prevention, control and" exact="therapy" post="of influenza. Although several compounds have been reported to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3434157/results/search/medproc/results.xml">
   <result pre="(90) 20.9% (136) Alone 20.1% (46) 34.7% (146) 26.5% (172)" exact="Vaccination" post="for seasonal influenza 4.4% (10) 5.5% (23) 5.1% (33)"/>
   <result pre="Vaccination for seasonal influenza 4.4% (10) 5.5% (23) 5.1% (33)" exact="Vaccination" post="for 2009 H1N1 influenza * 47.6% (109) 56.1% (236)"/>
   <result pre="(1.033–2.346) With children 1.302 (0.836–2.027) With spouse only 0.912 (0.588–1.416)" exact="Vaccination" post="for 2009 H1N1 influenza 1.756 (1.284–2.400) 1.940 (1.357–2.774) I"/>
   <result pre="of respondents reported high compliance to the recommended PPE use." exact="Vaccination" post="status, positive attitudes towards PPE use, cultural factor (perceived"/>
   <result pre="( 2008) Practice and perception – a national survey of" exact="therapy" post="habits in sepsis. Crit Care Med 36: 2719– 2725."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3523505/results/search/medproc/results.xml">
   <result pre="intervention and resolved in &amp;lt;24 h of change in drug" exact="therapy" post="or specific treatment to prevent a further outcome. Severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3556854/results/search/medproc/results.xml">
   <result pre="in the era of HIV infection and highly active antiretroviral" exact="therapy" post="rollouts Clinical Infectious Diseases 2010 50 3 S231 S237"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3571988/results/search/medproc/results.xml">
   <result pre="WHO Guidance Intubation, and related procedures (e.g. manual ventilation, suction)" exact="Intubation" post="and related procedures, e.g. manual ventilation Cardiopulmonary resuscitation Cardiopulmonary"/>
   <result pre="manual ventilation, suction) Intubation and related procedures, e.g. manual ventilation" exact="Cardiopulmonary resuscitation" post="Cardiopulmonary resuscitation Bronchoscopy Bronchoscopy Autopsy/surgery Autopsy procedures Non-invasive positive"/>
   <result pre="suction) Intubation and related procedures, e.g. manual ventilation Cardiopulmonary resuscitation" exact="Cardiopulmonary resuscitation" post="Bronchoscopy Bronchoscopy Autopsy/surgery Autopsy procedures Non-invasive positive pressure ventilation"/>
   <result pre="Bronchoscopy 7.1 12.9 8.6 Respiratory &amp;amp;Airway Suction 0.7 0.9 1.4" exact="Intubation" post="0.0 0.3 0.0 10.1371/journal.pone.0056278.t003 Table 3 The % of"/>
   <result pre="Respiratory &amp;amp;Airway Suction 14 (11) 22.4 29.7 47.9 1,852 (1,543–2,7521)" exact="Intubation" post="5 (4) 0.0 100.0 0.0 2,838 (2,838–2,838) Figure 1"/>
   <result pre="respiratory tract specimen collection 1 1 0 0 – –" exact="Intubation" post="&amp;amp; related procedures 5 5 1 (1) 7 2,838"/>
   <result pre="(0.52–28.1) High frequency oscillatory ventilation 6 6 0 – –" exact="Intubation" post="and related procedures 20 20 3 (2) 2,838 (1,543–20,614)"/>
   <result pre="Lower respiratory tract specimen collection 1 1 0 – –" exact="Intubation" post="&amp;amp; related procedures 5 5 1 (1) 2,838 (2,838–2,838)"/>
   <result pre="(0.43–25.9) High frequency oscillatory ventilation 6 6 0 – –" exact="Intubation" post="and related procedures 20 20 3 (2) 2,838 (1,543–20,614)"/>
   <result pre="126 87 Chest physiotherapy (2007) 8 1 0.082 996 82" exact="Intubation" post="(2007) 20 3 0.097 833 81 Chest physiotherapy (2009)"/>
   <result pre="833 81 Chest physiotherapy (2009) 10 2 0.131 532 70" exact="Intubation" post="(2009) 5 1 0.118 284 33 Lower respiratory tract"/>
   <result pre="in positive air samples by a factor of 4.37 (CI = 0.60–32.0)." exact="Intubation" post="and related procedures and respiratory/airway suctioning show decreased IRRs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3591312/results/search/medproc/results.xml">
   <result pre="time of testing was not associated with exhaled copy numbers." exact="Vaccination" post="in any prior year was associated with a non-significant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3733609/results/search/medproc/results.xml">
   <result pre="RM Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis" exact="therapy" post="initiation in South Africa Clin Infect Dis 2013 56"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3742513/results/search/medproc/results.xml">
   <result pre="United States of America [9], Influenza Division, National Center for" exact="Immunization" post="and Respiratory Diseases, Centers for Disease Control and Prevention,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3764173/results/search/medproc/results.xml">
   <result pre="Protection against Lethal Influenza Virus Challenge in Mice by Intranasal" exact="Vaccination" post=". PLOS ONE 7: e30252. doi: 10.1371/journal.pone.0030252. PubMed: 22279575."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3840630/results/search/medproc/results.xml">
   <result pre="patients from other patients Isolated 124 (71.26) Pharmaceutical prevention Provided" exact="Vaccination" post="service Provided 165 (94.83) PPE: personal protective equipment, ILI:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3944849/results/search/medproc/results.xml">
   <result pre="y/sex/profession Procedure Transmission route Ribavirin for postexposure prophylaxis Ribavirin for" exact="therapy" post="(no. d after symptom onset) Fatal Episode 1; survived,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC3957004/results/search/medproc/results.xml">
   <result pre="postpartum (within 2 weeks after delivery) Children receiving chronic aspirin" exact="therapy" post="Persons with obesity Residents of long-term care facilities Healthcare"/>
   <result pre="for each of the above basic elements are presented below." exact="Vaccination" post="Vaccination is the most effective way to prevent influenza."/>
   <result pre="each of the above basic elements are presented below. Vaccination" exact="Vaccination" post="is the most effective way to prevent influenza. Vaccination"/>
   <result pre="Vaccination Vaccination is the most effective way to prevent influenza." exact="Vaccination" post="on healthcare workers and hospitalized patients is a basic"/>
   <result pre="basic element for preventing influenza outbreak in a medical institution." exact="Vaccination" post="against seasonal influenza should be undertaken every year before"/>
   <result pre="(within 2 weeks after delivery) - Children receiving chronic aspirin" exact="therapy" post="- Persons with obesity - Residents of long-term care"/>
   <result pre="month after the first dose to obtain the appropriate immunity." exact="Vaccination" post="for hospitalized patients Vaccination against seasonal influenza is universally"/>
   <result pre="dose to obtain the appropriate immunity. Vaccination for hospitalized patients" exact="Vaccination" post="against seasonal influenza is universally recommended to all people"/>
   <result pre="acute illnesses without fever, influenza vaccination should be considered cautiously." exact="Vaccination" post="should be undertaken without delay in patients under long"/>
   <result pre="influenza vaccination. Then vaccination should be performed for unvaccinated patients." exact="Vaccination" post="for healthcare workers Influenza vaccination to healthcare workers prevents"/>
   <result pre="they are to stay in individual rooms or cohorts. 3)" exact="Vaccination" post="Influenza vaccination should be provided to patients and medical"/>
   <result pre="and chemoprophylaxis of influenza. Recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP) MMWR Recomm Rep 2011 60 1 24"/>
   <result pre="RC Prospective comparative study of culture specimens and methods in" exact="diagnosing" post="influenza in adults BMJ 1998 316 275 9472512 28"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4144793/results/search/medproc/results.xml">
   <result pre="detailed recommendations for latent TB infection (LTBI) screening and preventive" exact="therapy" post="among HCWs in their TB guidelines [5]. In these"/>
   <result pre="a single-step TST (5 international units; 0.1 ml) [13], [14]." exact="Vaccination" post="against TB with Bacillus Calmette-Guerin (BCG) is routinely offered"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4173431/results/search/medproc/results.xml">
   <result pre="and if it is positive thus one should take drug" exact="therapy" post="for TB as indicated. Swine flu Many patients of"/>
   <result pre="35 11 2 16 Tom DJ Gulevich SJ Shapiro HM" exact="Epidural" post="blood patch in the HIV-positive patient. Review of clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4230886/results/search/medproc/results.xml">
   <result pre="18 IU/L, ALT 24 IU/L). Renal function was normal. Initial" exact="therapy" post="consisted of IV fluids and ceftriaxone, fluconazole, and omeprazole."/>
   <result pre="basis of fevers, sweating and an abnormal chest radiograph, outpatient" exact="therapy" post="for tuberculosis was started. However, her condition continued to"/>
   <result pre="represent the informal consensus of experienced clinicians and investigators. Supportive" exact="therapy" post="is the mainstay [20]. The pathogenesis of severe cases"/>
   <result pre="Patient enrolment is currently ongoing for prospective trials of statin" exact="therapy" post="after the development of sepsis. N-acetylcysteine is an antioxidant"/>
   <result pre="Craven RB , et al. ( 1986) Lassa fever. Effective" exact="therapy" post="with ribavirin. N Engl J Med 314: 20– 26."/>
   <result pre="T , et al. ( 2006) High-volume hemofiltration as salvage" exact="therapy" post="in severe hyperdynamic septic shock. Intensive Care Med 32:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4244175/results/search/medproc/results.xml">
   <result pre="antibody targeting a4b1, is considered to be a highly effective" exact="therapy" post="in RRMS. The efficacy of NTZ is related to"/>
   <result pre="four-year, prospective, open-label study was conducted in RRMS patients initiating" exact="therapy" post="with NTZ, who were previously naïve to NTZ therapy."/>
   <result pre="this ongoing four-year study. Results: Twenty-five patients with RRMS initiating" exact="therapy" post="with NTZ participated. At year 2 mean tNAA/ tCr"/>
   <result pre="of British Columbia, Physics and Astronomy, Vancouver, BC, Canada Background:" exact="Magnetic resonance imaging" post="(MRI) techniques assessing T 2 relaxation can measure myelin"/>
   <result pre="induces cortical atrophy in white matter diseases is still debated." exact="Neuroimaging" post="studies of the sensory-motor cortex in patients with severe"/>
   <result pre="Sciences, University at Buffalo, State University of New York, Buffalo" exact="Neuroimaging" post="Analysis Center, Department of Neurology, Buffalo, NY, United States,"/>
   <result pre="CDMS in patients with CIS patients on a standard disease-modifying" exact="therapy" post="(DMT). To the best of our knowledge, this is"/>
   <result pre="Faber 2, F Weber 2 1Max Planck Institute of Psychiatry," exact="Neuroimaging" post="Research Group, Munich, Germany, 2Max Planck Institute of Psychiatry,"/>
   <result pre="activity to optimize treatment and possibly improve the clinical outcome." exact="Magnetic resonance imaging" post="(MRI) is a central tool in MS follow-up and"/>
   <result pre="all MS patients starting IFNβ treatment as a first line" exact="therapy" post="in the MS Centre of Catalonia, 105 patients were"/>
   <result pre="(not more than 3 months prior) and 12 months after" exact="therapy" post="onset in all patients. Statistical Parametric Mapping 8 software"/>
   <result pre="final cohort of 84 patients. Demographic and clinical characteristics at" exact="therapy" post="onset are as follows: mean age was 33.6 years"/>
   <result pre="affects brain volume dynamics during the first year of IFNβ" exact="therapy" post="mostly due to white matter loss. Baseline inflammation has"/>
   <result pre="making in clinically stable patients who are receiving disease modifying" exact="therapy" post="(DMT). Objectives: To determine the utility of MRI in"/>
   <result pre="measures of inhibitory control. P530 Predictor status of disease modifying" exact="therapy" post="time-exposure to brain atrophy using NeuroQuant AS Nielsen 1,2,"/>
   <result pre="Filippi 1,2 1San Raffaele Scientific Institute, Vita-Salute San Raffaele University," exact="Neuroimaging" post="Research Unit, Institute of Experimental Neurology, Milan, Italy, 2San"/>
   <result pre="Filippi 1,2 1San Raffaele Scientific Institute, Vita-Salute San Raffaele University," exact="Neuroimaging" post="Research Unit, Institute of Experimental Neurology, Milan, Italy, 2San"/>
   <result pre="QC, Canada, 3Biogen Idec Inc., Cambridge, MA, United States Background:" exact="Diffusion tensor imaging" post="(DTI) and magnetization transfer imaging (MTI) are increasingly utilized"/>
   <result pre="the periventricular, juxtacortical, and infratentorial white matter of the brain." exact="Magnetic resonance imaging" post="(MRI) sensitively detects white matter lesions (WML). Fluid-attenuated inversion"/>
   <result pre="32, mean age: 36.1). Fourteen patients were receiving no medical" exact="therapy" post="(NT), 17 immunomodulatory baseline therapy (BT) and 13 escalation"/>
   <result pre="patients were receiving no medical therapy (NT), 17 immunomodulatory baseline" exact="therapy" post="(BT) and 13 escalation therapy (ET). The latter were"/>
   <result pre="therapy (NT), 17 immunomodulatory baseline therapy (BT) and 13 escalation" exact="therapy" post="(ET). The latter were treated with Natalizumab, recently reported"/>
   <result pre="vitamin D and T2 lesions or BPF in RRMS subjects." exact="Diffusion tensor imaging" post="data will be available at the time of presentation."/>
   <result pre="1, B Weinstock-Guttman 2 1State University of New York, Buffalo" exact="Neuroimaging" post="Analysis Center, Buffalo, NY, United States, 2State University of"/>
   <result pre="integrity are associated with the pathological processes of MS lesions." exact="Magnetic resonance imaging" post="(MRI) plays an important role in the diagnosis and"/>
   <result pre="Research, Göttingen, Germany Background: Glucocorticoids (GCs) are the standard first-line" exact="therapy" post="for Multiple Sclerosis (MS) patients suffering an acute relapse."/>
   <result pre="behavior is significantly altered in MS patients undergoing methylprednisolone pulse" exact="therapy" post="(Acta Neuropathologica 127, 713-29), we are currently analyzing whether"/>
   <result pre="provide another explanation for the therapeutic effects of high-dose GC" exact="therapy" post="in MS patients. P572 Molecular dynamics and intracellular signalling"/>
   <result pre="4University of British Columbia, Medicine (Neurology), Vancouver, BC, Canada Background:" exact="Magnetic resonance imaging" post="(MRI) is useful for demonstrating areas of damage which"/>
   <result pre="normalization of both function and homeostasis of Treg under prolonged" exact="therapy" post="with Interferon-beta (IFN-beta) we additionally tested treatment effects of"/>
   <result pre="recruited to the study. 14 from MS patients received IFN-β1a" exact="therapy" post="at least 1 year (MS/IFN-β group). Serum level of"/>
   <result pre="Identification of novel protein candidates involved in immunomodulatory processes in" exact="therapy" post="and pathomechanism of multiple sclerosis MJ Knop 1, S"/>
   <result pre="for Psychiatry, Proteomics and Biomarkers, Munich, Germany Background: One approved" exact="therapy" post="of patients with relapsing-remitting MS is glatiramer acetate (GA)."/>
   <result pre="health through questions, online surveys and reviews. Surveys: physical/work or" exact="therapy" post="access, sleep diseases, nutrition/dietary, sexual dysfunction. The blog is"/>
   <result pre="chemokines but reciprocally boosted CD39 signals in the disease-state CNS." exact="Ablation" post="of TLR2 negated the protective function of PSA. PSA"/>
   <result pre="collected from those with MS either naïve or off current" exact="therapy" post="(no oral or infused DMT) for at least 30"/>
   <result pre="plasmapheresis in refractory patients. AQP4-IgG seropositivity supports the use of" exact="therapy" post="based on humoral immunity, such as plasmapheresis, but differences"/>
   <result pre="multiple sclerosis, exacerbations are often more severe, respond less to" exact="therapy" post="and leave a residual deficit. High-dose IV steroid therapy"/>
   <result pre="to therapy and leave a residual deficit. High-dose IV steroid" exact="therapy" post="(HD-S) and plasma exchange (PLEX) are recommended treatments of"/>
   <result pre="of relapses requiring a second, third, forth, and fifth line" exact="therapy" post="were 30%, 8%, 1%, 1%, respectively. After the last"/>
   <result pre="and HD-S and PLEX most commonly used. Escalation of relapse" exact="therapy" post="improves remission in some patients. P641 Clinical and radiological"/>
   <result pre="found in age, gender, ethnicity, body mass index, and corticosteroids" exact="therapy" post="between the groups (p&amp;gt;0.05). The median age of disease"/>
   <result pre="were pre-treatment + 0.8, 54% vs - 0.05, 88%. Conclusions:" exact="Immunosuppressive therapy" post="is the ‘current standard of care’ to prevent relapses."/>
   <result pre="pre-treatment + 0.8, 54% vs - 0.05, 88%. Conclusions: Immunosuppressive" exact="therapy" post="is the ‘current standard of care’ to prevent relapses."/>
   <result pre="ours support their use but will not exclude other factors." exact="Immunosuppressive therapy" post="may also reduce the residual damage from relapses. Our"/>
   <result pre="support their use but will not exclude other factors. Immunosuppressive" exact="therapy" post="may also reduce the residual damage from relapses. Our"/>
   <result pre="is influenced by ethnicity, onset age and attack type. P650" exact="Magnetic resonance imaging" post="features of optic neuritis distinguishing neuromyelitis optica from multiple"/>
   <result pre="MM was restarted. In April 2013 she developed right-sided hemiparesis." exact="Neuroimaging" post="showed worsening of her thoracic spine lesion and a"/>
   <result pre="by one month and suggests that neural preservation or protection" exact="therapy" post="must be delivered earlier to significantly prevent loss of"/>
   <result pre="(ON) represents a single-lesion model to explore multiple sclerosis (MS)." exact="Functional magnetic resonance imaging" post="transfer function (fMRI-TF) measures the resting state (no-activity) gain"/>
   <result pre="Swansea, United Kingdom, 5Istituto Superiore di Sanità, Rome, Italy Background:" exact="Neuroimaging" post="and neuropathology studies indicate that accumulating grey matter (GM)"/>
   <result pre="of its relation with the disease activity and disease modifying" exact="therapy" post="(DMT) of MS, a comparative analysis of endothelial function"/>
   <result pre="under immunomodulatory or immunosuppressive treatment, was excluded from the study." exact="Echocardiography" post="and HRV analysis with using 24-hour period Holter monitoring"/>
   <result pre="period Holter monitoring were performed in all of the subjects." exact="Echocardiography" post="was used to detect the presence of cardiac pathology."/>
   <result pre="receptor beta agonist, in preclinical development for neuroprotective and regenerative" exact="therapy" post="of multiple sclerosis P Fagergren 1, S Tiwari-Woodruff 2,"/>
   <result pre="increased risk of cancer and thrombosis, represent a novel neuroregenerative" exact="therapy" post="of Multiple Sclerosis. Karo Bio has discovered and developed"/>
   <result pre="warranting further development of KB3944 as a neuroprotective and regenerative" exact="therapy" post="of MS. P716 The role of vitamin D and"/>
   <result pre="multi-center, double-blind, three-arm trial that randomized 1008 participants to combination" exact="therapy" post="[interferon (IFN) and glatiramer acetate (GA)] versus each agent"/>
   <result pre="Filippi 1,2 1San Raffaele Scientific Institute, Vita-Salute San Raffaele University," exact="Neuroimaging" post="Research Unit, Institute of Experimental Neurology, Milan, Italy, 2San"/>
   <result pre="often in children than adults. Corticosteroids are usually first line" exact="therapy" post="and outcome is usually good. Objectives: To describe treatment"/>
   <result pre="1 1State University of New York, Dept. of Neurology, Buffalo" exact="Neuroimaging" post="Analysis Center, Buffalo, NY, United States, 2State University of"/>
   <result pre="performed in the 3 months prior and 12 months after" exact="therapy" post="onset), and followed-up for at least 48 months. Presence"/>
   <result pre="(RRMS) who are at risk of disease progression may facilitate" exact="therapy" post="adjustment. The modified Rio score (MRS) stratifies by disease"/>
   <result pre="sclerosis (MS) who are at risk of poor outcomes facilitates" exact="therapy" post="adjustment. The modified Rio score (MRS) is used to"/>
   <result pre="Sciences, University at Buffalo, State University of New York, Buffalo" exact="Neuroimaging" post="Analysis Center, Department of Neurology, Buffalo, NY, United States,"/>
   <result pre="Predictors of disability accrual in multiple sclerosis patients on first-line" exact="therapy" post="T Spelman 1, V Jokubaitis 1, G Izquierdo 2,"/>
   <result pre="were analysed using adjusted quantile median regression. Continuation on first-line" exact="therapy" post="was not a condition for remaining in the analysis."/>
   <result pre="EDSS increase. Increasing proportion of the observation period on DMT" exact="therapy" post="was associated with a significant decrease in EDSS change"/>
   <result pre="their primary aim was to evaluate the effect of a" exact="therapy" post="on QoL or to validate the use of a"/>
   <result pre="the two year period. ACTIVE patients switched drug and discontinued" exact="therapy" post="more frequently (A: 30% and 35%, I: 12% and"/>
   <result pre="illness intrusiveness. P794 Prevalence of adverse events with long-term disease-modifying" exact="therapy" post="and their impact on quality of life in patients"/>
   <result pre="treatment-naïve. In patients with previous DMT (65%), reasons for switching" exact="therapy" post="were needle fatigue, intolerance, lack of efficacy, poor QoL"/>
   <result pre="providers with an understanding of the patient perspective in Natalizumab" exact="therapy" post="in order to guide practice towards new tools to"/>
   <result pre="Neurology, Hamburg, Germany Background: Natalizumab (NAT) is a highly effective" exact="therapy" post="in relapsing multiple sclerosis (MS), yet bears the risk"/>
   <result pre="reported earlier menopausal age (p&amp;lt; 0.001) and more hormone replacement" exact="therapy" post="(HRT, p=0.02) use than natural menopause. In our primary"/>
   <result pre="a trend of increasing concerns regarding teratogenicity of disease modifying" exact="therapy" post="(DMT) was noted in later decades. Declining use of"/>
   <result pre="was noted in later decades. Declining use of hormone replacement" exact="therapy" post="(HRT) was also noted over time, with less use"/>
   <result pre="pose potential risks. Women typically are advised to discontinue interferon-beta" exact="therapy" post="before trying to conceive; however, if a neurologist does"/>
   <result pre="to interferon beta (IFNb), 2 to cyclophosphamide. Two patients remained" exact="therapy" post="free. All the patients were followed for at least"/>
   <result pre="clinical examination and brain MRI performed before starting the new" exact="therapy" post="and in case of relapse. Results: Between month 4"/>
   <result pre="Australia Background: The comparative long term safety profile of disease-modifying" exact="therapy" post="(DMT) in MS treatment is unknown. Although adverse events"/>
   <result pre="An unselected cohort of 613 MS patients who discontinued NTZ" exact="therapy" post="were extracted from the Italian iMedWeb registry. The relapse"/>
   <result pre="of infections and malignancies in patients who received continuous rituximab" exact="therapy" post="for at least 3 years. Methods: This was a"/>
   <result pre="(mean age: 41 years) receiving interferon beta or glatiramer acetate" exact="therapy" post="observed for 3 years, served as control group. There"/>
   <result pre="Neurology, Lugano, Switzerland Background: Fingolimod (FTY) is the first oral" exact="therapy" post="approved for the treatment of relapsing remitting multiple sclerosis"/>
   <result pre="(mitoxantrone, natalizumab). In September 2012, 6 months after the last" exact="therapy" post="was stopped, she was started with FTY 0.5 mg"/>
   <result pre="(RRMS) who had not responded after a course of immunomodulatory" exact="therapy" post="(IMT), and in those with aggressive onset of disease."/>
   <result pre="Specialists, Salt Lake City, UT, United States Background: While natalizumab" exact="therapy" post="is highly efficacious for the treatment of multiple sclerosis"/>
   <result pre="Disability progression associated with transitioning treatment after 2-years of natalizumab" exact="therapy" post="as reported by NARCOMS participants AR Salter 1, SS"/>
   <result pre="after correcting for multiple comparisons. Conclusions: Transitioning to a different" exact="therapy" post="after 2 years of NAT was associated with an"/>
   <result pre="(treatment-naive [CARE-MS I; NCT00530348] or who had relapsed on prior" exact="therapy" post="[CARE-MS II; NCT00548405]) received intravenous infusions of alemtuzumab 12"/>
   <result pre="patients. According to recent studies JCV reactivation occurs during NTZ" exact="therapy" post="and leads to an increase in the index levels"/>
   <result pre="United States. Objectives: As the majority of patients needing escalation" exact="therapy" post="in the German center for MS in childhood and"/>
   <result pre="stratification established from 3 factors: JC-virus seropositive status, prior immune" exact="therapy" post="and treatment exposure duration (over two years). In a"/>
   <result pre="she presented hypoesthesia/dysestesia at right limbs, treated with IV steroid" exact="therapy" post="with optimal response. The other case is a 32"/>
   <result pre="gestation), she presented right limbs hyposthenia/hypoesthesia, treated with IV steroid" exact="therapy" post="with good response. The 3 rd case is a"/>
   <result pre="gestation), she presented lower limb hypoesthesia, treated with IV steroid" exact="therapy" post="with good response. Conclusions: NAT withdrawal for pregnancy may"/>
   <result pre="in the majority of MS patients. Stem cells and cell-based" exact="therapy" post="P889 MicroRNA and gene expression profiling related to stem"/>
   <result pre="3Hospital Puerta de Hierro, Hematology, Majadahonda, Spain Background: In MS," exact="therapy" post="with autologous mesenchymal stem cells has an attractive potential"/>
   <result pre="(AHSCT); to extend this analysis after AHSCT to test if" exact="therapy" post="has modifying effects on MSCs and circulating monocytes. Methods:"/>
   <result pre="of MS pathology, as CXCL10 over production, do not determine" exact="therapy" post="outcome. P898 Autologous hematopoietic stem cell transplant in patients"/>
   <result pre="cells before clinical use. P902 Assessment of bone marrow-derived cell" exact="therapy" post="in progressive multiple sclerosis (ACTiMuS) CM Rice 1, DI"/>
   <result pre="Rocca 1,2 1San Raffaele Scientific Institute, Vita-Salute San Raffaele University," exact="Neuroimaging" post="Research Unit, Institute of Experimental Neurology, Milan, Italy, 2San"/>
   <result pre="females and 42 males (F:M ratio 0.76). Mean age at" exact="therapy" post="start was 48,5 years (22,4-76,9) and mean disease duration"/>
   <result pre="to present our 14-year experience on implementing the intrathecal baclofen" exact="therapy" post="(ITB) for the symptomatic treatment of spasticity in MS"/>
   <result pre="Berg, Germany, 2Clinical Analysis, Research and Application, Kleinmachnow, Germany Background:" exact="Palliative care" post="is a special challenge in the treatment of multiple"/>
   <result pre="the cerebello-pallido-thalamo-cortical network and could explain the efficacy of onabotulinumtoxin-A" exact="therapy" post="in the treatment of MS tremor. P927 Efficiency sulbutiamine"/>
   <result pre="novel option, but the procedures can be risky and expensive." exact="Radiosurgery" post="provides an alternative option for traditional surgery with potentially"/>
   <result pre="z=−2.57, p&amp;lt; 0.05). Conclusions: Our data show that fampridine PR" exact="therapy" post="positively impacts cognitive performance in MS patients by enhancing"/>
   <result pre="were recruited during clinic visits. Patients on testosterone or anti-androgen" exact="therapy" post="or with a relapse in the past month were"/>
   <result pre="the outcome of IFNβ treatment prior to the initiation of" exact="therapy" post="for MS management. Objectives: This project aims to identify"/>
   <result pre="Technology, Amsterdam, Netherlands Background: The anti-inflammatory effect of natalizumab, second-line" exact="therapy" post="for relapsing-remitting multiple sclerosis (RRMS) in most countries, leads"/>
   <result pre="collected from healthy controls and RRMS patients before starting fingolimod" exact="therapy" post="and 3 months after treatment initiation. Natural Treg frequency"/>
   <result pre="cell chemotaxis and migration, and rescue blood-brain barrier integrity. Laquinimod" exact="therapy" post="may restrict lesion pathogenesis in RRMS and other inflammatory"/>
   <result pre="6 months of treatment. Methods: Twelve RRMS patients starting natalizumab" exact="therapy" post="were included in the study. Dynamic images of brain"/>
   <result pre="non-coding transcripts. Genes were considered as differentially expressed genes during" exact="therapy" post="compared to baseline if they showed a fold-change&amp;gt;2.0 and"/>
   <result pre="CD4+ and CD8+ T cells decreased after 1 month of" exact="therapy" post="(median number of CD3+ from 1281/ul to 267/ul, CD4+"/>
   <result pre="double negative, DN) increased during the first 14 days of" exact="therapy" post="(from 20.60% to 43.10% among iNKT). Conclusions: FTY increased"/>
   <result pre="play a role in MS pathogenesis and is reversed by" exact="therapy" post="with interferon-β K Fainberg 1, K Regev 1, O"/>
   <result pre="capacity and the levels of anti TNFα binding Ab. IFNβ1a" exact="therapy" post="normalized the TNFα neutralization capacity. This is an unreported"/>
   <result pre="relapsing-remitting multiple sclerosis (MS); although the clinical efficacy of this" exact="therapy" post="has been demonstrated consistently in large, randomized, placebo-controlled trials,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4251210/results/search/medproc/results.xml">
   <result pre="therapies for treatment of EVD virus; however the mainstay of" exact="therapy" post="is supportive care. Emergency department personnel on the frontlines"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4257796/results/search/medproc/results.xml">
   <result pre="11 (22.9) Feeding 11 (22.9) Intravenous catheter placement 11 (22.9)" exact="Radiography" post="5 (10.4) Present during medical procedures* Airway suction 24"/>
   <result pre="treatment 14 (29.2) Sputum induction 11 (22.9) Bronchoscopy 4 (8.3)" exact="Intubation" post="3 (6.3) Infection control precautions used during patient contact*"/>
   <result pre="the Division of Viral Diseases of the National Center for" exact="Immunization" post="and Respiratory Diseases at the US Centers for Disease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4285246/results/search/medproc/results.xml">
   <result pre="intubation; and a hypotensive episode after intubation, which required vasopressor" exact="therapy" post="for 24 h. The patient was treated with intravenous"/>
   <result pre="of illness) ( Table 1). Oral and then intravenous ribavirin" exact="therapy" post="were initiated; the intravenous ribavirin was administered within 24"/>
   <result pre="laboratory abnormalities were initially attributed to side effects of ribavirin" exact="therapy" post="(particularly the elevated bilirubin level and gastrointestinal discomfort); in"/>
   <result pre="blood product requirements, and improved end-organ function). Continuous renal replacement" exact="therapy" post="was particularly helpful in controlling the patient’s life-threatening metabolic"/>
   <result pre="helpful in controlling the patient’s life-threatening metabolic derangements; hepatic replacement" exact="therapy" post="was of uncertain benefit and interfered with the optimal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4286619/results/search/medproc/results.xml">
   <result pre="required personnel should be in attendance in the room. Specific" exact="therapy" post="and vaccination At present, no specific therapy or vaccine"/>
   <result pre="the room. Specific therapy and vaccination At present, no specific" exact="therapy" post="or vaccine is effective for EVD. Typical antivirals, such"/>
   <result pre="or to assist with resuscitation. As there is no approved" exact="therapy" post="for EVD, the meticulous use of PPE is required"/>
   <result pre="Walley KR Use of central venous oxygen saturation to guide" exact="therapy" post="Am J Respir Crit Care Med 2011 184 514"/>
   <result pre="Brunkhorst FM Engel C Bloos F et al. Intensive insulin" exact="therapy" post="and pentastarch resuscitation in severe sepsis N Engl J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4377015/results/search/medproc/results.xml">
   <result pre="2000. These two targets were embedded within the directly observed" exact="therapy" post="– short course (DOTS) strategy launched by WHO in"/>
   <result pre="attitudes and practices of health care providers towards isoniazide preventive" exact="therapy" post="(IPT) provision in Addis Ababa, Ethiopia August, 2013 available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4420971/results/search/medproc/results.xml">
   <result pre="to 1.12) 1.03 (0.34 to 3.13) 0.65 (0.34 to 1.22)" exact="Vaccination" post="0.83 (0.27 to 2.52) 1.74 (0.24 to 12.56) 1.27"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4456839/results/search/medproc/results.xml">
   <result pre="it was reviewed by a multidisciplinary team including the respiratory" exact="therapy" post="department. It is extremely important as respiratory therapists that"/>
   <result pre="AGPs is identified and our needs are met. All respiratory" exact="therapy" post="departments should be proactive and ensure that their hospitals"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4459682/results/search/medproc/results.xml">
   <result pre="the detection of EVD, intensive care supportive facilities, renal replacement" exact="therapy" post="and a process for fast tracking accessibility to any"/>
   <result pre="(48 %) in hospitals that would admit patients. Renal replacement" exact="therapy" post="is in place for patients with renal failure due"/>
   <result pre="(47.7) 23 (35.4) 14 (25.0) 20 (35.7) 0.21 Renal replacement" exact="therapy" post="is available for patients with renal failure due to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4480394/results/search/medproc/results.xml">
   <result pre="21 (47) Emergency department 11 (24) Multiple locations 12 (27)" exact="Computed tomography" post="suite 1 (2) Personal protective equipment worn while in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4601968/results/search/medproc/results.xml">
   <result pre="also observed on the right lateral neck ( Fig. 1C)." exact="Computed tomography" post="(CT) scanning revealed multiple lymph nodes swelling on paratracheal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4634525/results/search/medproc/results.xml">
   <result pre="and policymakers. Influenza pandemic mathematical models public health policy antiviral" exact="therapy" post="vaccination non‐pharmaceutical measures fig-count: table-count: page-count: Background Influenza pandemics"/>
   <result pre="influenza pandemic can be contained at the source if antiviral" exact="therapy" post="for a sizable proportion of affected individuals (80–90%) is"/>
   <result pre="can increase our lead time for pandemic vaccine production. 3" exact="Immunization" post="of children can result in significant changes in contact"/>
   <result pre="efficacy may also vary in different age groups. 4 Antiviral" exact="therapy" post="is the cornerstone of the pandemic response in Canada"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4634655/results/search/medproc/results.xml">
   <result pre="or work situation (RR = 1·13, P = 0·03), although the effect was modest." exact="Vaccination" post="Seasonal influenza vaccination The majority of respondents received the"/>
   <result pre="number of questions assessed limits our analysis to trends only." exact="Vaccination" post="The CDC recommends annual vaccinations for people currently working"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4640848/results/search/medproc/results.xml">
   <result pre="optimal respiratory samples to allow early diagnosis and initiation of" exact="therapy" post="for children with TB. The Xpert MTB/RIF assay [Cepheid,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4696151/results/search/medproc/results.xml">
   <result pre="prep areas ▪ Radiology ▪ Nuclear Medicine ▪ MRI ▪" exact="Endoscopy" post="Unit ▪ Outpatient Physical Therapy (Rehab) ▪ Psychiatric Services"/>
   <result pre="Stores ▪ Laboratories ▪ Medical Units ▪ Surgical Units ▪" exact="Hemodialysis" post="Unit ▪ Bone Marrow Transplant Unit ▪ Burn Intensive"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4776863/results/search/medproc/results.xml">
   <result pre="patients from MDR-TB diagnosis to death, despite receiving directly observed" exact="therapy" post="with isoniazid, rifampicin, pyrazinamide, ethambutol, along with the high"/>
   <result pre="new TB patients having unrecognized MDR-TB may not receive adequate" exact="therapy" post="and continue spreading resistant organisms in health establishments. Also,"/>
   <result pre="1162 7 http://dx.doi.org/10.1378/chest.111.5.1162 9149564 Menon S Early initiation of antiretroviral" exact="therapy" post="and universal HIV testing in sub-Saharan Africa: Has WHO"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4787138/results/search/medproc/results.xml">
   <result pre="All 12 patients needed MV, 11 needed vasopressors, renal replacement" exact="therapy" post="was needed in seven patients, and median duration of"/>
   <result pre="rooms, especially during high-risk procedures such as bronchoscopy, intubation, nebulisation" exact="therapy" post="or tracheal suction.[ 16] These recommendations are evidence-based and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC4910139/results/search/medproc/results.xml">
   <result pre="Med 31 1998 370 375 9506496 7 Advisory Committee on" exact="Immunization" post="Practices; Centers for Disease Control and Prevention (CDC) Immunization"/>
   <result pre="on Immunization Practices; Centers for Disease Control and Prevention (CDC)" exact="Immunization" post="of health-care personnel: recommendations of the Advisory Committee on"/>
   <result pre="Immunization of health-care personnel: recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP) MMWR Recomm Rep 60 2011 1 45"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5053544/results/search/medproc/results.xml">
   <result pre="Assessment: Systematic Reviews : Biology and Life Sciences : Immunology:" exact="Vaccination" post="and Immunization : Medicine and Health Sciences : Immunology:"/>
   <result pre="Reviews : Biology and Life Sciences : Immunology: Vaccination and" exact="Immunization" post=": Medicine and Health Sciences : Immunology: Vaccination and"/>
   <result pre="Vaccination and Immunization : Medicine and Health Sciences : Immunology:" exact="Vaccination" post="and Immunization : Medicine and Health Sciences : Public"/>
   <result pre="Immunization : Medicine and Health Sciences : Immunology: Vaccination and" exact="Immunization" post=": Medicine and Health Sciences : Public and Occupational"/>
   <result pre="Health Sciences : Public and Occupational Health : Preventive Medicine:" exact="Vaccination" post="and Immunization : Research and Analysis Methods : Mathematical"/>
   <result pre=": Public and Occupational Health : Preventive Medicine: Vaccination and" exact="Immunization" post=": Research and Analysis Methods : Mathematical and Statistical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5063897/results/search/medproc/results.xml">
   <result pre="Rassi A The benefit trial: Testing the hypothesis that trypanocidal" exact="therapy" post="is beneficial for patients with chronic chagas heart disease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5097379/results/search/medproc/results.xml">
   <result pre="regular screening of healthcare workers for TB; and Isoniazid preventative" exact="therapy" post="(IPT) and antiretroviral treatment (ART) for HIV positive patients"/>
   <result pre="Healthcare associated infections HIV Human immunodeficiency virus IPT Isoniazid preventative" exact="therapy" post="MDR Multi-drug resistant ORs Odds ratios PHC Primary health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5168865/results/search/medproc/results.xml">
   <result pre="were performed at day 13 after transplantation and steroid pulse" exact="therapy" post="was conducted due to elevated concentration of serum creatinine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5425829/results/search/medproc/results.xml">
   <result pre="2314-6141 Hindawi pmcid: 5425829 doi: 10.1155/2017/7565706 : Clinical Study Endotracheal" exact="Intubation" post="Using a Direct Laryngoscope and the Protective Performances of"/>
   <result pre="the participant's neck to support the weight of the tubes." exact="Intubation" post="was performed using the Macintosh laryngoscope, which has a"/>
   <result pre="= 0.081) ( Table 2). 3.3. Fit Factors during the" exact="Intubation" post="Phase There was no significant difference when we compared"/>
   <result pre="respirators, and 2 participants (8.7%) preferred the cup-type respirators. 3.5." exact="Intubation" post="Time and Success Rate All three respirators had similar"/>
   <result pre="decrease the protective performance of some respirators [ 10, 11]." exact="Intubation" post="using a video laryngoscope could solve this problem, by"/>
   <result pre="J. C. Mosier J. M. Chiu S. Keim S. M." exact="Tracheal intubation" post="in the emergency department: a comparison of GlideScope® video"/>
   <result pre="(171–180) Weight (kg) 75 (69–80) Postgraduate years (years) 4 (3–6)" exact="Intubation" post="experiences (times) 80 (50–100) Face width (mm) 138.17 (10.84)"/>
   <result pre="100 (78.61–100) 100 (100-100) 100 (76.1–100) 0.081 0.031 0.266 0.104" exact="Intubation" post="phase Fit factor 200 (102.75–200) 200 (200-200) 142.5 (63.5–200)"/>
   <result pre="74.16 (36.1–98.91) 100 (91.61–100) 62.5 (8.13–100) 0.011 &amp;lt;0.001 0.118 &amp;lt;0.001" exact="Intubation" post="time Intubation time † (seconds) 33.24 (2.58) 28.69 (1.55)"/>
   <result pre="100 (91.61–100) 62.5 (8.13–100) 0.011 &amp;lt;0.001 0.118 &amp;lt;0.001 Intubation time" exact="Intubation" post="time † (seconds) 33.24 (2.58) 28.69 (1.55) 29.88 (1.63)"/>
   <result pre="33.24 (2.58) 28.69 (1.55) 29.88 (1.63) 0.247 0.324 0.70 1.00" exact="Intubation" post="success rate Intubation success rate (percent) 24 (100) 24"/>
   <result pre="(1.55) 29.88 (1.63) 0.247 0.324 0.70 1.00 Intubation success rate" exact="Intubation" post="success rate (percent) 24 (100) 24 (100) 24 (100)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5446130/results/search/medproc/results.xml">
   <result pre="classification of adventitious sounds is useful to assist physicians in" exact="diagnosing" post="or monitoring diseases such as asthma, Chronic Obstructive Pulmonary"/>
   <result pre="respiratory system. These can usually be heard by performing auscultation." exact="Auscultation" post="is generally carried out to check physical health, and"/>
   <result pre="characteristics may not be general and representative for different patients." exact="Auscultation" post="Auscultation is the medical term referring to the use"/>
   <result pre="may not be general and representative for different patients. Auscultation" exact="Auscultation" post="is the medical term referring to the use of"/>
   <result pre="to high-pitched sounds while the bell is for low-pitched sounds." exact="Auscultation" post="is recommended to be performed in a quiet environment"/>
   <result pre="the sounds clearly [ 8]. Drawbacks and Limitations of Conventional" exact="Auscultation" post="The first limitation of conventional auscultation is that it"/>
   <result pre="cannot be performed frequently and thus cannot provide continuous monitoring." exact="Auscultation" post="needs to be performed by an expert, especially when"/>
   <result pre="[ 128], Understanding Lung Sounds 3 rd Edition [ 129]," exact="Auscultation" post="Skills: Breath and Heart Sounds [ 130], Fundamentals of"/>
   <result pre=", Madabhavi I , Niranjan N , Dogra M ." exact="Auscultation" post="of the respiratory system. Ann Thorac Med. 2015; 10("/>
   <result pre="PA, USA: WB Saunders Company; 2002. 130 Lippincott W ." exact="Auscultation" post="Skills: Breath and Heart Sounds, the 3rd edition Philadelphia,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5480889/results/search/medproc/results.xml">
   <result pre="Prevention (Biological) Therapeutic/pharmaceutical approaches to prevent contraction of Ebola Ebola" exact="Vaccination" post="3. 2 Primary Prevention (Environmental) Environmental and behavioral modifications"/>
   <result pre="Brincidofovir, convalescent serum) 3.4.8 Supportive treatments are only option/no specific" exact="therapy" post="4 Trust and role of institutions Trust in information"/>
   <result pre="outcomes, the lack of universality is an important caveat for" exact="diagnosing" post="clinicians. As stated in the methods, articles were scored"/>
   <result pre=". The Ebola epidemic crystallizes the potential of passive antibody" exact="therapy" post="for infectious diseases . PLoS Pathog. 2015; 11( 4):"/>
   <result pre="Curcumin suppression of cytokine release and cytokine storm. A potential" exact="therapy" post="for patients with Ebola and other severe viral infections"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5493079/results/search/medproc/results.xml">
   <result pre="P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet" exact="therapy" post="is associated with increased mortality rates in severe sepsis"/>
   <result pre="Singer, H. S. Jafri P099 - Short-term inhaled colistin adjunctive" exact="therapy" post="for ventilator-associated pneumonia Y. Nassar, M. S. Ayad P100"/>
   <result pre="unit (ticu) patients – Tehran, Iran H. Talaie P109 -" exact="Phage therapy" post="against antimicrobial resistance, design of the first clinical study"/>
   <result pre="(ticu) patients – Tehran, Iran H. Talaie P109 - Phage" exact="therapy" post="against antimicrobial resistance, design of the first clinical study"/>
   <result pre="Aldabbagh, R. Khan, Y. Arabi P111 - Does empiric antifungal" exact="therapy" post="improve survival in septic critically ill patients? (immunocompromised excluded)"/>
   <result pre="Multiorgan Donor(PMD) F. Righetti, E. Colombaroli, G. Castellano P147 -" exact="Echocardiography" post="in the potential heart donor exposed to substitution hormonotherapy"/>
   <result pre="M. Cecconi P161 - Analysis of duration of post-operative goal-directed" exact="therapy" post="protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff,"/>
   <result pre="HES solution do not reduce total fluid requirement in the" exact="therapy" post="of patients with burn shock V. Bagin, V. Rudnov,"/>
   <result pre="0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid" exact="therapy" post="on gastrointestinal feeding intolerance in mechanically ventilated patients receiving"/>
   <result pre="using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid" exact="therapy" post="in adults in ICU after heart surgery S. Reddy,"/>
   <result pre="urinary output: potential parameters for early initiation of renal replacement" exact="therapy" post="K. Maas, H. De Geus P183 - Renal replacement"/>
   <result pre="therapy K. Maas, H. De Geus P183 - Renal replacement" exact="therapy" post="for critically ill patients: an intermittent continuity E. Lafuente,"/>
   <result pre="P184 - A survey of practices related to renal replacement" exact="therapy" post="in critically ill patients in the north of England."/>
   <result pre="28-day mortality in critically ill patients necessitating continuous renal replacement" exact="therapy" post="S. Stads, A. J. Groeneveld P186 - The impact"/>
   <result pre="on outcomes in acute kidney injury patients receiving renal replacement" exact="therapy" post="on the intensive care unit I. Elsayed, N. Ward,"/>
   <result pre="- Citrate regional anticoagulation for post dilution continuous renal replacement" exact="therapy" post="S. Ghabina P189 - Citrate 18 mmol/l improves anticoagulation"/>
   <result pre="P195 - Observations in early vs. late use of cytosorb" exact="therapy" post="in critically ill patients K. Kogelmann, M. Drüner, D."/>
   <result pre="A. Ozcan, C. Kaymak P219 - Anaesthesia procedure and intensive" exact="therapy" post="in patients with neck phlegmon V. A. Artemenko, A."/>
   <result pre="and normal adult breathing profiles during nasal high flow oxygen" exact="therapy" post="L. Sweeney, A . O’ Sullivan, P. Kelly, E."/>
   <result pre="O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat P446 -" exact="Palliative care" post="consultation and intensive care unit admission request: a cohort"/>
   <result pre="who may decide E. Koonthalloor, C. Walsh P449 - Correctly" exact="diagnosing" post="death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud"/>
   <result pre="defined refractory shock as septic shock unresponsive to the conventional" exact="therapy" post="such as adequate fluid resuscitation and vasopressor therapy to"/>
   <result pre="the conventional therapy such as adequate fluid resuscitation and vasopressor" exact="therapy" post="to maintain hemodynamics. Results: The serial change of C1INH"/>
   <result pre="at admission and day 1. The validity of C1INH replacement" exact="therapy" post="in patients with septic shock may lead to a"/>
   <result pre="abdominal sepsis. Recently, blood purification (BF) such as endotoxin absorption" exact="therapy" post="(polymyxin B [PMX] hemoperfusion) and continuous renal replacement therapy"/>
   <result pre="absorption therapy (polymyxin B [PMX] hemoperfusion) and continuous renal replacement" exact="therapy" post="(CRRT) has been carried out for abdominal septic shock."/>
   <result pre="Hospices Civils de Lyon / bioMérieux, Lyon, France Introduction: Despite" exact="therapy" post="improvement septic shock mortality is still around 30 %."/>
   <result pre="criteria poses a diagnostic dilemma that can lead to delayed" exact="therapy" post="or overly aggressive treatment. This study quantified concordance of"/>
   <result pre="to infection, in which the speed and appropriateness of the" exact="therapy" post="administered in the initial hours are likely to influence"/>
   <result pre="increase by disease severity. This probably reflects the difficulty in" exact="diagnosing" post="early sepsis. P039 Vasodilatory plant extracts gel as an"/>
   <result pre="ICU stay, duration of cardiovascular support, need for renal replacement" exact="therapy" post="(RRT) and ICU survival were noted. Results: A total"/>
   <result pre="Biostatistics and analyses, Masaryk University, Brno, Czech Republic Introduction: Vasopressor" exact="therapy" post="is required to sustain life and maintain perfusion in"/>
   <result pre="Italy Introduction: Low-dose vasopressin (VP) recently emerged as a promising" exact="therapy" post="for septic shock[1]. The rationale for its use is"/>
   <result pre="hospital mortality and need for vasopressors, ventilation and renal replacement" exact="therapy" post="(RRT). Results: Of 1,397 ICU admissions 517 had sepsis"/>
   <result pre="liver diseases, chronic kidney failure, hematologic diseases, pregnancy, chronic anticoagulant/antiplatelet" exact="therapy" post="and blood derivates or procoagulant treatments in the last"/>
   <result pre="endogenous anticoagulants. Thereby, ROTEM may be a useful tool in" exact="diagnosing" post="DIC in the critically ill. Table 5 (Abstract P054)."/>
   <result pre="0.468* 0.258 *p &amp;lt; 0.05,**p &amp;lt; 0.01 P055 Cessation of a preexisting chronic antiplatelet" exact="therapy" post="is associated with increased mortality rates in severe sepsis"/>
   <result pre="sepsis [1, 2]. But it remains unclear, if chronic antiplatelet" exact="therapy" post="should be continued or not during severe sepsis and"/>
   <result pre="blood cell (RBC) transfusion in patients with continued chronic antiplatelet" exact="therapy" post="remains to be determined. We hypothesized that the continuation"/>
   <result pre="of a preexisting antiplatelet medication (aspirin, clopidogrel, dipyridamole) during sepsis" exact="therapy" post="reduces mortality rates of severe sepsis and septic shock"/>
   <result pre="represented as percentages and counts. Results: Patients whose preexisting antiplatelet" exact="therapy" post="was continued showed increased mortality rates in contrast to"/>
   <result pre="antiplatelet agents (p &amp;gt; 0.05). Conclusions: The continuation of a chronic antiplatelet" exact="therapy" post="during severe sepsis and septic shock was associated with"/>
   <result pre="for diagnostic results to become available, which can adversely impact" exact="therapy" post="and clinical outcomes. Molecular techniques to diagnose CRBSI are"/>
   <result pre="mechanical ventilation 90% 83.3% Cardiovascular support 90% 100% Renal replacement" exact="therapy" post="20% None Length of stay in ICU in hours"/>
   <result pre="mechanical ventilation. All patients received 3-doses of trivalent anti-botulinum toxin" exact="therapy" post="within 24 hours of clinical diagnosis. The diagnosis was"/>
   <result pre="bacteria which is accompanied by poor outcome due to inappropriate" exact="therapy" post="led to the investigation if adjunctive treatment with Pentaglobin,"/>
   <result pre="87.1 % of the patients during the ICU stay, vasopressor" exact="therapy" post="in 80.6 %, and renal replacement therapy in 51.6"/>
   <result pre="ICU stay, vasopressor therapy in 80.6 %, and renal replacement" exact="therapy" post="in 51.6 %. The overall ICU mortality rate was"/>
   <result pre="invasive mechanical ventilation (95.7 vs. 62.5 %, p = 0.48) and vasopressor" exact="therapy" post="(95.7 vs. 37.5 %, p = 0.002). Conclusions: MERS-CoV infection requiring"/>
   <result pre="4 were treated with proning, 4 needed continuous renal replacement" exact="therapy" post="and one had extracorporeal membrane oxygenation. The hospital mortality"/>
   <result pre="VS 92.0 %). In turn, more patients received appropriate antibiotic" exact="therapy" post="(86.7 % VS 100 %). Of note, 6 patients"/>
   <result pre="Results: N/A Conclusions: The SAATELLITE study represents an innovative pre-emptive" exact="therapy" post="approach to prevent S aureus nosocomial pneumonia in MV"/>
   <result pre="to randomization. Conclusions: The EVADE study represents an innovative pre-emptive" exact="therapy" post="approach to prevent P aeruginosa nosocomial pneumonia in MV"/>
   <result pre="infection management in high-risk patients. P099 Short-term inhaled colistin adjunctive" exact="therapy" post="for ventilator-associated pneumonia Y. Nassar, M. S. Ayad Cairo"/>
   <result pre="colistin (3x 106 IU/day, for 5 days) as an adjunctive" exact="therapy" post="to conventional treatment of VAP (n = 52 pts) or enter"/>
   <result pre="VAP (n = 52 pts) or enter the control group of conventional" exact="therapy" post="only (n = 33 pts). Comparison included microbiological outcome (Day 6"/>
   <result pre="Adjunctive inhaled colistin is safe and effective as an additive" exact="therapy" post="in patients with gram-negative ventilator-associated pneumonia. P100 Effect of"/>
   <result pre="hospital ICU, were without pre-existing kidney injury, and received colistin" exact="therapy" post="72 or more hours were included. Patient demographics, the"/>
   <result pre="Bobi, M. Rigol, A. Torres Hospital Clinic, Barcelona, Spain Introductions:" exact="Nebulization" post="of antibiotics is a promising strategy for the treatment"/>
   <result pre="nebulized F; nebulized AF with Mero administered IV; Mero alone." exact="Nebulization" post="was performed through an in-line vibrating mesh nebulizer (PARI"/>
   <result pre="onset was between 1-15 days (median 4) after initiation of" exact="therapy" post="with resolution within 3 days (median 2) of cessation"/>
   <result pre="to pathogenic organisms. To treat the inflammatory reaction an antibiotic" exact="therapy" post="is fundamental [1]. Effects of disease pattern and intensive"/>
   <result pre="Therefore we analysed changes of beat-to-beat cardiac activity during antibiotic" exact="therapy" post="of intensive care patients with a high resolution electrocardiogram."/>
   <result pre="(p &amp;lt; 0,05). This variation persisted for the first three minutes of" exact="therapy" post="and returns during the next two minutes to their"/>
   <result pre="as nephrotoxicity and bicytopeniasignificantly were decreased in teicoplanin therapy. P109" exact="Phage therapy" post="against antimicrobial resistance, design of the first clinical study"/>
   <result pre="nephrotoxicity and bicytopeniasignificantly were decreased in teicoplanin therapy. P109 Phage" exact="therapy" post="against antimicrobial resistance, design of the first clinical study"/>
   <result pre="control randomized trial ever done in the world about phage" exact="therapy" post="in humans. Results will be available in 2016. Phages"/>
   <result pre="be routinely considered for antibiotic dosing. P111 Does empiric antifungal" exact="therapy" post="improve survival in septic critically ill patients? (immunocompromised excluded)"/>
   <result pre="of invasive candidiasis (IC) remains a major challenge. Delayed antifungal" exact="therapy" post="is known as an independent mortality factor in Septic"/>
   <result pre="in Septic shock attributed to IC [1]. Thus, empiric antifungal" exact="therapy" post="(EAFT) can be indicated in septic patients at risk"/>
   <result pre="acute bleeding. PCC should be used as a first line" exact="therapy" post="for anticoagulation reversal of vitamin k antagonist. References Josepg"/>
   <result pre="transfusion PRBC for 11 % and decreasing volume of infusion" exact="therapy" post="for 19 % compared to patients of 2 ng"/>
   <result pre="is an useful alternative to labINR for guiding blood component" exact="therapy" post="after CPB. Fig. 23 (Abstract P126). ᅟ P127 Disseminated"/>
   <result pre="A major haemorrhage protocol improves the delivery of blood component" exact="therapy" post="and reduces waste in trauma massive transfusion. Injury. 2013,"/>
   <result pre="&amp;amp; Reddy P. Atrial fibrillation after cardiac surgery: does rophylactic" exact="therapy" post="decrease adverse outcomes associated with atrial fibrillation. J Intensive"/>
   <result pre="estimated glomerular filtration rate, and 2) need for renal replacement" exact="therapy" post="during 90 days. The secondary endpoints were 1) length"/>
   <result pre="in serum levels of creatinine and cystatin C, renal replacement" exact="therapy" post="rate (1 of 37 patients in the ANP group"/>
   <result pre="1 - 10). Rhythm control strategy was used as first-line" exact="therapy" post="for the majority of patients: 81 % received intravenous"/>
   <result pre="septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87. P147" exact="Echocardiography" post="in the potential heart donor exposed to substitution hormonotherapy"/>
   <result pre="systolic function, despite the stunning post neurovegetative storm. Reference 1." exact="Echocardiography" post="in the potential heart donor. Venkateswaran RV et al.:"/>
   <result pre="in post-operative patients. P161 Analysis of duration of post-operative goal-directed" exact="therapy" post="protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff,"/>
   <result pre="describe the timing for achieving targets of the post-operative goal-directed" exact="therapy" post="(GDT) protocol in postoperative patients admitted to ICU in"/>
   <result pre="School, Canberra, Australia Introductions: Fluid bolus administration is a ubiquitous" exact="therapy" post="within Intensive Care, however recent evidence has suggested a"/>
   <result pre="salt solution was the most commonly used for fluid bolus" exact="therapy" post="in our unit, independent of patient disease or severity."/>
   <result pre="injuries, transfusions and management were collected, as well as fluid" exact="therapy" post="and mechanical ventilation during ICU stay. Patients were classified"/>
   <result pre="ventilation duration in non-survivors group. The use of extra renal" exact="therapy" post="was higher in non-survivors group (1 vs 11 p = 0.01)."/>
   <result pre="HES solution do not reduce total fluid requirement in the" exact="therapy" post="of patients with burn shock V. Bagin, V. Rudnov,"/>
   <result pre="to access the efficacy and safety of HES in the" exact="therapy" post="of patients with burn shock. Methods: Design: retrospective cohort"/>
   <result pre="24 patients received 6%HES 130/0,4 in addition to base fluid" exact="therapy" post="with Ringer solution and control group: 25 patients received"/>
   <result pre="for RRT. Addition of HES solution in the early infusion" exact="therapy" post="is not associated with the reduce of total fluid"/>
   <result pre="0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid" exact="therapy" post="on gastrointestinal feeding intolerance in mechanically ventilated patients receiving"/>
   <result pre="using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid" exact="therapy" post="in adults in ICU after heart surgery S. Reddy"/>
   <result pre="trial. All adult heart surgery patients who required crystalloid fluid" exact="therapy" post="in ICU as part of the SPLIT trial [1]"/>
   <result pre="to the potentially fatal INH hepatitis. HAGMA refractory to conventional" exact="therapy" post="is one of the hallmarks of INH toxicity. Though"/>
   <result pre="urinary output: potential parameters for early initiation of renal replacement" exact="therapy" post="K. Maas, H. De Geus Erasmus Medical Centre, Rotterdam,"/>
   <result pre="increased mortality in the critically ill, especially when renal replacement" exact="therapy" post="(RRT) is required. &quot;Early initiation&quot; of RRT and its"/>
   <result pre="patients with any AKI compared with RRT P183 Renal replacement" exact="therapy" post="for critically ill patients: an intermittent continuity E. Lafuente"/>
   <result pre="Castelo, Portugal Introductions: The choice for the right renal replacement" exact="therapy" post="(RRT) for severe acute kidney injury in critically ill"/>
   <result pre="critically ill patients, indications for SLED and continuous renal replacement" exact="therapy" post="(CRRT) in critically ill patients in four Portuguese ICUs."/>
   <result pre="months. All patients with AKI who needed a renal replacement" exact="therapy" post="were enrolled. Data on demographics and clinical characteristics of"/>
   <result pre="CRRT seems to be the ideal mode of renal replacement" exact="therapy" post="for hemodynamically unstable with fluid overloaded. However, in expert"/>
   <result pre="complementary. P184 A survey of practices related to renal replacement" exact="therapy" post="in critically ill patients in the north of England."/>
   <result pre="up- to- date guideline regarding the use of renal replacement" exact="therapy" post="(RRT) within intensive care. We wished to evaluate current"/>
   <result pre="we hope to improve outcomes for those receiving renal replacement" exact="therapy" post="in our units. P185 High initiation creatinine associated with"/>
   <result pre="28-day mortality in critically ill patients necessitating continuous renal replacement" exact="therapy" post="S. Stads 1, A. J. Groeneveld 2 1Ikazia Hospital,"/>
   <result pre="Rotterdam, Netherlands Introductions: Acute kidney injury necessitating continuous renal replacement" exact="therapy" post="(CRRT) in critically ill patients is associated with high"/>
   <result pre="on outcomes in acute kidney injury patients receiving renal replacement" exact="therapy" post="on the intensive care unit I. Elsayed 1, N."/>
   <result pre="renal &amp;amp; patient survival in AKI patients, receiving renal replacement" exact="therapy" post="(RRT) in intensive care (ICU). Methods: We prospectively enrolled"/>
   <result pre="P188 Citrate regional anticoagulation for post dilution continuous renal replacement" exact="therapy" post="S. Ghabina Royal London Hospital, London, UK Introductions: S"/>
   <result pre="(RCA) is an effective anticoagulation technique for continuous renal replacement" exact="therapy" post="(CRRT). Commonly, RCA protocols incorporate citrate within the replacement"/>
   <result pre="of severe sepsis/septic shock. Therefore, CytoSorb was used as adjunctive" exact="therapy" post="in combination with continuous renal replace therapy (CRRT), in"/>
   <result pre="used as adjunctive therapy in combination with continuous renal replace" exact="therapy" post="(CRRT), in order to control the cytokines storm and"/>
   <result pre="a timely use of CytoSorb in combination with the standard" exact="therapy" post="could have benefits in improving patients hemodynamic and helping"/>
   <result pre="83 ± 3.2 P195 Observations in early vs. late use of cytosorb" exact="therapy" post="in critically ill patients K. Kogelmann 1, M. Drüner"/>
   <result pre="to increased cytokine levels [1]. CytoSorb is used as adjunctive" exact="therapy" post="not only in septic multiorgan failure as well as"/>
   <result pre="14 Patients treated additional with cytokine-haemadsorption filter (Cytosorb) as adjunctive" exact="therapy" post="in septic shock or severe SIRS. The focus was"/>
   <result pre="to show the effectiveness of Cytosorb treatment used as adjunctive" exact="therapy" post="in critically ill patients. If there was no decrease"/>
   <result pre="decrease of catecholamine demand and kidney injury persistent after initial" exact="therapy" post="following actual guidelines [2], Cytosorb therapy was initiated. We"/>
   <result pre="injury persistent after initial therapy following actual guidelines [2], Cytosorb" exact="therapy" post="was initiated. We collected data before, during and after"/>
   <result pre="overall survival was 35,7 %. In contrast, survival in Cytosorb" exact="therapy" post="start delay 24 h was 66.7 %. Poor outcome"/>
   <result pre="outcome increased in patients with late start of Cytosorb (survivors:" exact="therapy" post="start delay &amp;lt; 48 h: 50 %, delay &amp;gt; 48 h: none). Cytosorb"/>
   <result pre="therapy start delay &amp;lt; 48 h: 50 %, delay &amp;gt; 48 h: none). Cytosorb" exact="therapy" post="start in nonsurvivors was by far later than in"/>
   <result pre="than in survivors (61,3 h vs 28,8 h). After Cytosorb" exact="therapy" post="we observed pronounced decrease of catecholamine demand (Norepinephrine μg/h"/>
   <result pre="renal failure or late admission to ICU. This implicates a" exact="therapy" post="start not later than 24 – 48 hours. References"/>
   <result pre="given loop diuretics, 10(19 %) started on continuous renal replacement" exact="therapy" post="(CRRT), fluid boluses to 21(39 %). In 1 (2"/>
   <result pre="postrenal obstruction with urineaccumulation. Ultrasound(US) is the procedure of choice" exact="diagnosing" post="this cause of AKI and hence choosing the best"/>
   <result pre="a programme for the education of students and physicians in" exact="diagnosing" post="obstruction via US in an expert like manner. Methods:"/>
   <result pre="the length(cm) of the right kidney of a female volunteer,(ii)" exact="diagnosing" post="postrenal obstruction by evaluating images from US examinations. FARIUS"/>
   <result pre="develop acute renal failure (ARF) and require a renal replacement" exact="therapy" post="(RRT). The best delay to start RRT is a"/>
   <result pre="surgery (ERAS) pathways incorporate the use of goal directed fluid" exact="therapy" post="with cardiac output monitoring perioperatively. Our study aim was"/>
   <result pre="to be around 30 % with need for renal replacement" exact="therapy" post="up to 1 %. [1] We aim to characterize"/>
   <result pre="cadaver-kidney transplantations should be increased. P219 Anaesthesia procedure and intensive" exact="therapy" post="in patients with neck phlegmon V. A. Artemenko, A."/>
   <result pre="to 72 hours after decreasing inflammatory, larynges edema, and trizm." exact="Intubation" post="algorithm: 1. Evaluate risk difficult intubation, trizm and stridor;"/>
   <result pre="UK Introduction: Nasal high flow oxygen (NHFO) is an attractive" exact="therapy" post="for acute hypoxemic respiratory failure (AHRF), with reported comfort,"/>
   <result pre="at present to support use of NHFO rather than conventional" exact="therapy" post="for acute hypoxemic respiratory failure in adults, and further"/>
   <result pre="and normal adult breathing profiles during nasal high flow oxygen" exact="therapy" post="L. Sweeney, A. O’ Sullivan, P. Kelly, E. Mukeria,"/>
   <result pre="to dose consistency by aerosol delivery during nasal high flow" exact="therapy" post="(NHF). We sought to investigate the efficiency of dosing"/>
   <result pre="at both high and low gas flow rates via NHF" exact="therapy" post="is an efficient and highly reproducible means of administration."/>
   <result pre="to evaluate the usefulness of the CL test and corticosteroid" exact="therapy" post="in the prevention of UAO. P226 A device for"/>
   <result pre="daily hydroelectrolitic rebalancing, calculation of individual energy need and symptomatic" exact="therapy" post="was performed. Along with the improvement of general condition,"/>
   <result pre="are not without their limitations. These include blockages and aerosol" exact="therapy" post="(AT) associated issues [3-4]. PH manufacturers have identified the"/>
   <result pre="Non-invasive ventilation (NIV) is commonly used as a first line" exact="therapy" post="for immunocompromised patients with acute respiratory failure, although it"/>
   <result pre="that if it is interact with the noninvasive ventilation (NIV)" exact="therapy" post="in hypercapnic respiratory failure. Because of the frequent diuretic"/>
   <result pre="NIV screened retrospectively. Patients who received asetozolamid during the NIV" exact="therapy" post="excluded from the study. We investigated frequency, risk factors"/>
   <result pre="Rehabilitacion, Mexico City, Mexico Introduction: Mechanical ventilation (MV) is a" exact="therapy" post="for vital support used in a significant proportion of"/>
   <result pre="critically ill patients. The right time to succesfully discontinue this" exact="therapy" post="is a challenge for the intensivist The ecocardiographic evaluation"/>
   <result pre="curves on a global, but not on a regional level." exact="Electrical impedance tomography" post="(EIT) in contrast is an established non-invasive tool to"/>
   <result pre="and 57 % respectively). 57 % of patients underwent physical" exact="therapy" post="within a median of 5 days of starting ECMO"/>
   <result pre="or 1) can do well with mechanical circulatory support. Destination" exact="therapy" post="&amp;amp; commissioning remains a problem within the UK. Reference"/>
   <result pre="92.3 % (AUC 0.85; 95 % CI 0.684-0.945; p &amp;lt; 0.0001) for" exact="diagnosing" post="ARDS in NP. A complex ROC analysis (SPD + P/F ratio"/>
   <result pre="with both acute and acute-on-chronic liver failure. Extracorporeal liver support" exact="therapy" post="(ECLST) could be one of the treatment option. But"/>
   <result pre="high mortality rate without liver transplant, although extracorporeal liver support" exact="therapy" post="improved total bilirubin, creatinine and BUN. Nevertheless, the value"/>
   <result pre="hospital ICU beds in ES-Brazil. 151 critically patients with nutritional" exact="therapy" post="indication were enrolled. This retrospective study (nov13-nov14) we grouped"/>
   <result pre="1.2 g/kgBW/d [1]. Protein is an integral component of nutritional" exact="therapy" post="in critically ill patients which aims to minimise muscle"/>
   <result pre="stay (day+/-SD) 19.85 ± 20.43 26.78 ± 26.90 0.087 Vasopressor" exact="therapy" post="(%) 63.4% 80.0% 0.051 Duration of ventilator (day+/-SD) 14.19"/>
   <result pre="patients may be contraindicated, therefore 5-HTP can become an alternative" exact="therapy" post="in depression of patients in ICU. P294 Parenteral selenium"/>
   <result pre="on infections (P = 0.15). There was no effect of IV selenium" exact="therapy" post="on ICU LOS, hospital LOS, and ventilator days. Result"/>
   <result pre="1.04; P = 0.18) RR 0.95 (95% CI 0.85, 1.06; P = 0.36) Combined" exact="therapy" post="RR 1.08 (95% CI 0.93, 1.25; P = 0.33) RR 0.90"/>
   <result pre="intravenous drip infusion of a diuretic solution and renal replacement" exact="therapy" post="requirement in ICU. The study was conducted by an"/>
   <result pre="for CPR in a bundle approach including epinephrine and post-ROSC" exact="therapy" post="protocol. References Zamiri N, Massé S, Ramadeen A, Kusha"/>
   <result pre="and neurological outcome in patients with our without renal replacement" exact="therapy" post="(RRT). Methods Prospective cohort study at Oslo University Hospital,"/>
   <result pre="patients were randomly allocated in 2 groups to receive standard" exact="therapy" post="or 1800 mg of L-carnitine/ day together with standard"/>
   <result pre="therapy or 1800 mg of L-carnitine/ day together with standard" exact="therapy" post="for 3 days. Plasma levels of valproic acid and"/>
   <result pre="in patients equivocal LP findings or recurrent symptoms was CT" exact="Angiography" post="[2]. Conclusions The majority of patients presenting with acute"/>
   <result pre="delayed presentation or risk factors for SAH benefit from CT" exact="Angiography" post="unless contra-indicated. Our findings will be presented as an"/>
   <result pre="1.5 g twice daily (23.1 %). Median duration of LEV" exact="therapy" post="was 7 days. Seizures occurred in 7 patients during"/>
   <result pre="S, Nindra P, Ray S: Inhaled NO as a salvage" exact="therapy" post="in ARDS 2. Ferrando C, Moreno J, Soro M,"/>
   <result pre="30 %, respectively (0,03). Conclusions Dexmedetomidine addition to basic AWS" exact="therapy" post="with benzodiazepines and antipsychotics, may decrease risk of PTSD"/>
   <result pre="cardiovascular dysfunction, in 57.40 % of patients (N = 31). Renal replacement" exact="therapy" post="was required in 11 cases. Invasive ventilation was performed"/>
   <result pre="and INR, septic shock, noninvasive ventilation before intubation, renal replacement" exact="therapy" post="and chemotherapy administration in the ICU. Results: In the"/>
   <result pre="19 (15.4 %) patients during ICU stay. New renal replacement" exact="therapy" post="for acute kidney injury was used in 18 (14.6"/>
   <result pre="5.67; 95 % confidence interval, 1.92-16.75) and new renal replacement" exact="therapy" post="(odds ratio, 13.59; 95 % confidence interval, 1.14-161.93) were"/>
   <result pre="mortality (69 %). Male gender, septic shock and renal replacement" exact="therapy" post="were independent predictors of mortality. P403 Patient-important outcomes in"/>
   <result pre="invasive or non-invasive mechanical ventilation, vasopressor or commencing renal replacement" exact="therapy" post="and antibiotic treatment. Reference Orsini J, Blaak C, Shamian"/>
   <result pre="that mobilization of patients on low dose of vasoactive drugs" exact="therapy" post="may be possible and safe, with little complications and"/>
   <result pre="and appears safe in this short observation period. Interactive game" exact="therapy" post="may complement existing rehabilitation techniques and increase motivation for"/>
   <result pre="referred to palliative care, with its attendant cost savings. Conclusions:" exact="Palliative care" post="in the ICU is an important part of management"/>
   <result pre="of Critical Care Medicine. Crit Care Med. 1998 Mar;26(3):607-10. P446" exact="Palliative care" post="consultation and intensive care unit admission request: a cohort"/>
   <result pre="cardiac arrest or `Brain Dead.all patients who had limitation of" exact="therapy" post="had family consensus,of which 2 were autonomous decision of"/>
   <result pre="reasons for withdrawal of care was either unresponsive to maximal" exact="therapy" post="or irreversible neurologic status,The optimal use of resources and"/>
   <result pre="associated with increased satisfaction. Crit Care Med 2004;32:1484-1488 P449 Correctly" exact="diagnosing" post="death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud"/>
   <result pre="out the reviews were not involved in the process of" exact="diagnosing" post="death in order not to bias the study findings."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5582558/results/search/medproc/results.xml">
   <result pre="to the deoxyribonucleic acid. Cytotoxic drugs are used in the" exact="therapy" post="of various neoplastic conditions, organ transplantation, and collagen vascular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5662401/results/search/medproc/results.xml">
   <result pre="the emergency department. Abbreviations: CC = Chest compression, CPR =" exact="Cardiopulmonary resuscitation," post="MERS = Middle East Respiratory Syndrome, NIOSH = National"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5695630/results/search/medproc/results.xml">
   <result pre="to receive or do not complete latent TB infection (LTBI)" exact="therapy" post="[ 6]. Furthermore, multidrug-resistant (MDR) TB and extensively drug-resistant"/>
   <result pre="from CDC guidelines due to the delay in suspecting and" exact="diagnosing" post="active TB or placing patients with suspected active TB"/>
   <result pre="HCP and patients during LTBI testing, and the cost of" exact="therapy" post="for LTBI infection among those found to be infected"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5711301/results/search/medproc/results.xml">
   <result pre="and offered patient isolation, diagnosis, and oral and intravenous rehydration" exact="therapy" post="and medications. Therefore, we focused clinical management instruction on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5727565/results/search/medproc/results.xml">
   <result pre="non-MTB septic shock) and only one patient who received anti-TB" exact="therapy" post="after 24 hours survived [ 4]. In patients with"/>
   <result pre="of septic shock remain the same [ 19]. Initiating anti-TB" exact="therapy" post="can be challenging in the ICU patient. Issues include"/>
   <result pre="which is commonly seen in the critically ill patient. Standard" exact="therapy" post="for TB involves a combination of three or more"/>
   <result pre="Rivers E. Nguyen B. Havstad S. et al. Early goal-directed" exact="therapy" post="in the treatment of severe sepsis and septic shock"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5733382/results/search/medproc/results.xml">
   <result pre="CPR. Middle East Respiratory Syndrome Epidemiology Infectious disease transmission Patient-to-professional" exact="Cardiopulmonary resuscitation" post="Korea INTRODUCTION The Middle East Respiratory Syndrome (MERS), which"/>
   <result pre="A, who was hospitalized in hospital A in Daejeon without" exact="diagnosing" post="MERS infection, visited the emergency room of hospital B."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5779818/results/search/medproc/results.xml">
   <result pre="workers during a pandemic include all levels of infection controls." exact="Vaccination" post="along with the use of personal protective equipment (PPE)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5805185/results/search/medproc/results.xml">
   <result pre="911– 916. 21427399 2 Rashid H Khandaker G Booy R" exact="Vaccination" post="and herd immunity: what more do we know? Curr"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5856488/results/search/medproc/results.xml">
   <result pre="broad technological implications for tissue engineering, photodynamic therapy, bioactuators, medical" exact="therapy" post="equipment, and smart wearable devices. In conclusion, we have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5875572/results/search/medproc/results.xml">
   <result pre="guidelines for preventing the transmission of infections in hemodialysis facilities." exact="Hemodialysis" post="units Hospitals Infection control Practice guideline Introduction Patients with"/>
   <result pre="ESRD patients over 18 years old who are receiving hemodialysis" exact="therapy" post="in dialysis units. The areas of infection control covered"/>
   <result pre="Waste management Sterilizing, disinfecting, and cleaning Laundry care Environmental control" exact="Vaccination" post="1. Infection prevention and control program 1.1. Each dialysis"/>
   <result pre="After touching a patient’s surroundings (e.g., finishing dialysis therapy) 2.3." exact="Hemodialysis" post="patients, as well as their families and visitors, should"/>
   <result pre="contact or droplet precautions are required should either receive dialysis" exact="therapy" post="in a single-occupancy isolation room, by the cohort isolation"/>
   <result pre="the patient treatment area, storage room and clean area. 12." exact="Vaccination" post="12.1. Hepatitis B, pneumococcal, and influenza vaccinations are recommended"/>
   <result pre="750 757 2011 10.1016/j.ajic.2016.02.033 12 Gorski LA The 2016 infusion" exact="therapy" post="standards of practice Home Healthc Now 35 10 18"/>
   <result pre="recommendations for patients on chronic dialysis The Advisory Committee on" exact="Immunization" post="Practices and the American Academy of Pediatrics Semin Dial"/>
   <result pre="in the United States: recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP) Part II: immunization of adults MMWR Recomm"/>
   <result pre="Contact precaution + Droplet precaution Airborne precaution Patient placement Dialysis" exact="therapy" post="in a single-patient room or cohort isolation or at"/>
   <result pre="room or cohort isolation or at the last sequence Dialysis" exact="therapy" post="in a negative pressure room or a single-patient room"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5881326/results/search/medproc/results.xml">
   <result pre="liver function tests, coagulation studies and C-reactive protein (CRP) level," exact="Electrocardiography" post="and two-dimensional (2D) echocardiography were within the normal limits,"/>
   <result pre="a large complex cystic pelvic mass and metastatic peritoneal disease." exact="Colonoscopy" post="revealed an extrinsic compression of the rectum with luminal"/>
   <result pre="intravenous (IV) fentanyl (2 μg/kg) and IV propofol (2 mg/kg)." exact="Tracheal intubation" post="was facilitated with IV vecuronium (0.1 mg/kg) and appropriately"/>
   <result pre="et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant" exact="therapy" post="before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy World J"/>
   <result pre="2016 14 253 27678344 2 Ceelen WP Flessner MF Intraperitoneal" exact="therapy" post="for peritoneal tumors: Biophysics and clinical evidence Nat Rev"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5909605/results/search/medproc/results.xml">
   <result pre="Medicine and Health Sciences : Surgical and Invasive Medical Procedures:" exact="Intubation" post=": People and Places : Population Groupings : Professions"/>
   <result pre="GlideScope® with a GlideRite rigid stylet. (e) I-gel® airway device." exact="Intubation" post="was performed using the Laerdal airway management trainer (Laerdal"/>
   <result pre="regardless of whether or not the manikin’s lungs were inflated)." exact="Intubation" post="failure was deemed to have occurred when the tip"/>
   <result pre="100 100 0.01 0.176 0.028 0.068 (%) (90.4–100) (100–100) (100–100)" exact="Intubation" post="time Intubation time † 17.65 (5.67) 15.67 (7.54) 15.74"/>
   <result pre="0.01 0.176 0.028 0.068 (%) (90.4–100) (100–100) (100–100) Intubation time" exact="Intubation" post="time † 17.65 (5.67) 15.67 (7.54) 15.74 (5.63) (seconds)"/>
   <result pre="Intubation time † 17.65 (5.67) 15.67 (7.54) 15.74 (5.63) (seconds)" exact="Intubation" post="success rate Intubation success rate 26 (100) 26 (100)"/>
   <result pre="17.65 (5.67) 15.67 (7.54) 15.74 (5.63) (seconds) Intubation success rate" exact="Intubation" post="success rate 26 (100) 26 (100) 26 (100) (%)"/>
   <result pre="prevention of infection during intubation while wearing an N95 respirator." exact="Intubation" post="time and success rate The intubation time was longer"/>
   <result pre=", Mosier JM , Chiu S , Keim SM ." exact="Tracheal intubation" post="in the emergency department: a comparison of GlideScope® video"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC5970465/results/search/medproc/results.xml">
   <result pre="evidence, the exception being a package of HIV-testing, isoniazid preventive" exact="therapy" post="and access to anti-retroviral treatment for HCWs, which was"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6049013/results/search/medproc/results.xml">
   <result pre="leukocytosis, thrombocytopenia, elevated transaminases, and renal failure ( Table 2)." exact="Urinalysis" post="revealed occult blood and elevated protein. Lumbar puncture revealed"/>
   <result pre="in hearing. Tympanometry testing after hospital discharge revealed normal tympanograms." exact="Computed tomography" post="of the temporal bones was also normal. Repeat audiometric"/>
   <result pre="IJ , Webb PA , et al. Lassa fever. Effective" exact="therapy" post="with ribavirin. N Engl J Med 1986; 314: 20–"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6121424/results/search/medproc/results.xml">
   <result pre="2008 46 1024 1031 10.1086/528720 18444819 2. Englund J.A. Antiviral" exact="therapy" post="of influenza Semin. Pediatr. Infect. Dis. 2002 13 120"/>
   <result pre="V. Fedson D. Baldini J. Douglas R.G. Couch R.B. Amantadine" exact="therapy" post="of epidemic influenza A2 (Hong Kong) Infect. Immun. 1970"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6189356/results/search/medproc/results.xml">
   <result pre="control measures can be considered for achieving these goals. 6.1" exact="Vaccination" post="In portions the European Union, vaccination using a phase"/>
   <result pre="Guatteo R , Lehebel A , Joly A, Beaudeau F." exact="Vaccination" post="using phase I vaccine is effective to control Coxiella"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6207419/results/search/medproc/results.xml">
   <result pre="Diseases, Washington State Department of Health USA [d], Comprehensive Family" exact="Immunization" post="Unit, Pan American Health Organization USA [e], Pan American"/>
   <result pre="affected population and in surrounding communities, should also be completed." exact="Immunization" post="registry data, for example, has recently been used to"/>
   <result pre="population preferred • The largest possible area should be covered" exact="Vaccination" post="of infants aged 6–11 months as an outbreak control"/>
   <result pre="healthcare provider or local hospital for vaccination or immunoglobulin  ○" exact="Vaccination" post="clinics at health departments  ○ Community outreach (e.g., door-to-door"/>
   <result pre="clinics at health departments  ○ Community outreach (e.g., door-to-door vaccination)" exact="Vaccination" post="of susceptible individuals Guidance and evidence Vaccination of non-immune"/>
   <result pre="(e.g., door-to-door vaccination) Vaccination of susceptible individuals Guidance and evidence" exact="Vaccination" post="of non-immune individuals is considered the key strategy in"/>
   <result pre="Of note, patients already receiving subcutaneous immunoglobulin (IGSC) or IGIV" exact="therapy" post="are considered protected if, respectively, at least 200 mg/kg"/>
   <result pre="recommendations. In 2013, for example, the U.S. Advisory Committee on" exact="Immunization" post="Practices increased the recommended dose of IGIM to 0.5"/>
   <result pre="is a global shortage of plasma-derived products. Where available, IG" exact="therapy" post="can be expensive, requiring cold chain and sterile materials"/>
   <result pre="in computerized form at the facility for easy access. 3" exact="Vaccination" post="of healthcare personnel without evidence of immunity. 1– 3"/>
   <result pre="Provision of post-exposure prophylaxis (vaccine or immunoglobulin) to susceptible contacts." exact="Vaccination" post="includes giving a second dose to healthcare workers that"/>
   <result pre="R , Neuhauser H , Schlaud M , Schenk L" exact="Vaccination" post="coverage against measles in German-born and foreign-born children and"/>
   <result pre="and mumps, 2013: summary recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP) . MMWR Recomm Rep. 2013; 62( RR-04):"/>
   <result pre="doi: 10.1016/j.ajic.2007.10.007 . PMID:18068815 18068815 110. collab: Advisory Committee on" exact="Immunization" post="P, Centers for Disease C, Prevention Immunization of health-care"/>
   <result pre="Advisory Committee on Immunization P, Centers for Disease C, Prevention" exact="Immunization" post="of health-care personnel: recommendations of the Advisory Committee on"/>
   <result pre="Immunization of health-care personnel: recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP) . MMWR Recomm Rep. 2011; 60( RR-7):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6326489/results/search/medproc/results.xml">
   <result pre=", and stethescope e Bending at trunk, upper extremity use" exact="Auscultation" post="2 Standing at bedside 1.0–2.0 Palpate radial pulse and"/>
   <result pre="rate using wall-mounted clock Bending at trunk, upper extremity use" exact="Palpation" post="2 Standing at bedside 0.3–0.5 Determine respiratory rate Counting,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6435930/results/search/medproc/results.xml">
   <result pre="tests and mandated drug susceptibility testing (DST) and directly observed" exact="therapy" post="(DOT) for those undergoing TB treatment (Culture and Directly"/>
   <result pre="treatment technical instructions (TB TIs) using cultures and directly observed" exact="therapy" post="(DOT) for panel physicians [Internet] Atlanta Centers for Disease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6499148/results/search/medproc/results.xml">
   <result pre="a 44-year-old laser surgeon developed laryngeal papillomatosis after administering laser" exact="therapy" post="to patients with anogenital condylomas due to HPV infection."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6500621/results/search/medproc/results.xml">
   <result pre="result came back as sterile; still the baby needed photo" exact="therapy" post="as neonatal jaundice arose. The patient was extubated after"/>
   <result pre="will help to relieve symptoms and reduce viral shedding, but" exact="therapy" post="is more beneficial if started within 12-48 hours. Neuraminidase"/>
   <result pre="strict hand hygiene and cough etiquette [ 9, 10]. 7." exact="Immunization" post="Immunization is recommended to pregnant women especially during flu"/>
   <result pre="hand hygiene and cough etiquette [ 9, 10]. 7. Immunization" exact="Immunization" post="is recommended to pregnant women especially during flu season"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6545339/results/search/medproc/results.xml">
   <result pre="value Reference Π Recruitment rate 3,253,607 year −1 Estimated ν" exact="Vaccination" post="rate 0.4868 day −1 Assumed ε Vaccine efficacy 85%"/>
   <result pre="= 1 . The control u v represents vaccination rate." exact="Vaccination" post="rates for many diseases ranges from 0 to 100%."/>
   <result pre="Hausi H. Chriwa G. Steinglass R. Smith D. Valle M." exact="Vaccination" post="coverage and timely vaccination with valid doses in Malawi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6584931/results/search/medproc/results.xml">
   <result pre="DNA was in the plume collected during carbon dioxide laser" exact="therapy" post="of papilloma virus-infected verrucae. Next year, Sawchuk et al."/>
   <result pre="MC Lee C Kim SJ Efficacy and safety of photodynamic" exact="therapy" post="for cervical intraepithelial neoplasia: a systemic review Photodiagnosis Photodyn"/>
   <result pre="or &quot;Smoke and Mirrors&quot; in the Operating Theatre? Dermatology and" exact="therapy" post="2017 7 249 54 28484898 63 Taravella MJ Weinberg"/>
   <result pre="insuf fl ation and smoke-evacuation system in flexible gastrointestinal endoscopy" exact="Endoscopy" post="2016 48 579 83 27009080 81 Schultz L An"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6613683/results/search/medproc/results.xml">
   <result pre="prevalent and incident LTBI who were offered free isoniazid preventive" exact="therapy" post="(IPT), only 2 participants initiated and completed IPT. High"/>
   <result pre="Self-reported TB exposure is underreported, and uptake of LTBI prevention" exact="therapy" post="remains low. New approaches are needed to identify HCWs"/>
   <result pre="participants with prevalent and incident LTBI were offered isoniazid preventive" exact="therapy" post="(IPT) as required by the study protocol, yet only"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6645313/results/search/medproc/results.xml">
   <result pre="hospitals (84.4%) also referred PWAT to other institutions to continue" exact="therapy" post="( Table 4). However, confirmation of successful referral only"/>
   <result pre="high, at 95%. In addition, the provision of Isoniazid preventive" exact="therapy" post="(IPT) in PLHIV without active TB was found to"/>
   <result pre="78.6%. For PLHIV with active TB, the provision of antiretroviral" exact="therapy" post="(ART), overall, was 55.1%. Guarulhos had a figure of"/>
   <result pre="clinics. TABLE 3. Availability of bacteriological tests and criteria for" exact="diagnosing" post="tuberculosis (TB) in selected hospitals in five cities in"/>
   <result pre="14 87.5 50 39.1 Hospitals implementing both phases of directly-observed" exact="therapy" post="1 25.0 1 50.0 8 c 80.0 5 50.0"/>
   <result pre="14 82.4 14 87.5 89 69.5 Provision of Isoniazid preventive" exact="therapy" post="in people living with HIV (PLHIV) without active TB"/>
   <result pre="0.0 11 78.6 4 28.6 36 41.4 Provision of antiretroviral" exact="therapy" post="in PLHIV with active TB 5 62.5 1 50.0"/>
   <result pre="EL Hayes RJ et al. Efficacy of secondary isoniazid preventive" exact="therapy" post="among HIV-infected Southern Africans: time to change policy? AIDS"/>
   <result pre="Corbett EL, Hayes RJ, . Efficacy of secondary isoniazid preventive" exact="therapy" post="among HIV-infected Southern Africans: time to change policy? AIDS."/>
   <result pre="Kranzer K Lewis JJ Churchyard GJ Antiretrovirals and isoniazid preventive" exact="therapy" post="in the prevention of HIV-associated tuberculosis in settings with"/>
   <result pre="Kranzer K, Lewis JJ, Churchyard GJ. Antiretrovirals and isoniazid preventive" exact="therapy" post="in the prevention of HIV-associated tuberculosis in settings with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6660527/results/search/medproc/results.xml">
   <result pre="scenario for the calculation of release criteria established for 131I" exact="therapy" post="in Japan. Results A small peak for the 351-keV"/>
   <result pre="descendant nuclides of 219Rn in a room increased during radionuclide" exact="therapy" post="with 223Ra, compared with that without the patients ["/>
   <result pre="staff who stood close to the patients during 223RaCl 2" exact="therapy" post="were measured during two injections (three medical staff for"/>
   <result pre="documentation regarding the calculation of release criteria established for 131I" exact="therapy" post="by the Ministry of Health and Welfare in Japan"/>
   <result pre="Yoshihide Yanagida Sachiko Kinuya Seigo Introduction of the targeted alpha" exact="therapy" post="(with Radium-223) into clinical practice in Japan: learnings and"/>
   <result pre="alpha radionuclides in air from patients during Ra-223 alpha radionuclide" exact="therapy" post="Sci Rep. 2018 8 10976 10.1038/s41598-018-29449-9 30030499 4. Henriksen"/>
   <result pre="Y Yanagida S Kinuya S Introduction of the targeted alpha" exact="therapy" post="(with radium-223) into clinical practice in Japan: learnings and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6691429/results/search/medproc/results.xml">
   <result pre="specific treatment protocol for EVD and only supportive and symptomatic" exact="therapy" post="is the line of treatment. This review article provides"/>
   <result pre="management protocol. Ebola virus oral manifestations public health menace symptomatic" exact="therapy" post="Introduction Ebola, earlier termed as Ebola hemorrhagic fever (EHF),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6765846/results/search/medproc/results.xml">
   <result pre="pointed towards two themes: (a) the uncertainty inherent in accurately" exact="diagnosing" post="Valley Fever—making it a challenge to disseminate clear, simple"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6832307/results/search/medproc/results.xml">
   <result pre="recognized as important sources for nosocomial transmission of emerging viruses." exact="Intubation" post="was investigated as a possible cause of Ebola virus"/>
   <result pre="A.E. Stewart T.E. Transmission of Severe Acute Respiratory Syndrome during" exact="Intubation" post="and Mechanical Ventilation Am. J. Respir. Crit. Care Med."/>
   <result pre="Aerosols May Be Generated Bronchoscopy * Induced cough, respiratory tract" exact="Cardiopulmonary resuscitation" post="* Induced cough, respiratory tract Noninvasive ventilation * (BiPAP,"/>
   <result pre="(BiPAP, CPAP, HFOV) Possible mechanical dispersal of aerosols, respiratory tract" exact="Tracheal intubation" post="* Induced cough, respiratory tract Manual ventilation * Possible"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6841732/results/search/medproc/results.xml">
   <result pre="evaluate a MERS vaccine in dromedaries in endemic countries. Results" exact="Vaccination" post="and challenge of dromedaries Twenty calves (10 seronegative and"/>
   <result pre="day 0, with no significant differences between these two groups." exact="Vaccination" post="did not increase these titres at 28 d.p.i.; however"/>
   <result pre="be affected by pre-existing Abs at the time of vaccination." exact="Vaccination" post="resulted in a statistically significant reduction in virus shedding"/>
   <result pre="Ther., 10.1038/mt.2013.284 (2014). 35. Coughlan, L. et al. Heterologous Two-Dose" exact="Vaccination" post="with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6850237/results/search/medproc/results.xml">
   <result pre="media. Discussion WHO and RNTCP insist sputum smear microscopy for" exact="diagnosing" post="presumptive TB patients, initiating anti-tubercular drugs and monitoring disease"/>
   <result pre="to Rieder et al. who reported increase in percentage in" exact="diagnosing" post="presumptive TB patients from third specimen from 0.7% to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6854691/results/search/medproc/results.xml">
   <result pre="Dávi II Farmacêutica S.A., Barcarena, Portugal), during the whole procedure." exact="Electroretinography" post="Retinal physiology was evaluated using flash and pattern electroretinography"/>
   <result pre="100 μV peak to peak with a sample frequency of 1.136 kHz." exact="Magnetic resonance imaging" post="(MRI) Brain structure was evaluated using magnetic resonance imaging"/>
   <result pre="AD Alzheimer’s disease Aβ Amyloid beta CSF Cerebrospinal fluid ERG" exact="Electroretinography" post="fERG Flash electroretinography GCL Ganglion cell layer GM Gray"/>
   <result pre="nuclear layer IPL Inner plexiform layer IS Inner segment MRI" exact="Magnetic resonance imaging" post="OCT Optical coherence tomography ONL Outer nuclear layer OP"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6879156/results/search/medproc/results.xml">
   <result pre="and endodontic therapy. The main source of aerosols during dental" exact="therapy" post="is the patient’s mouth, which can cause spread of"/>
   <result pre="in the air of the dental treatment room during dental" exact="therapy" post="[ 4]. Even shortly following dental treatments, the dental"/>
   <result pre="[ 6]. Others have reported higher PM concentrations during dental" exact="therapy" post="procedures than during non-working periods (i.e., indoor background) ["/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6908682/results/search/medproc/results.xml">
   <result pre="dead space and also to control the temperature 36 ." exact="Vaccination" post="and antiviral agents as preventive and therapeutic measures are"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6970581/results/search/medproc/results.xml">
   <result pre="Type ofintervention Control group Population Length offollow-up ROBINS-I Outcome Effect" exact="Vaccination" post="effectiveness Michiels et al 12 Vaccination (TIV): n ="/>
   <result pre="offollow-up ROBINS-I Outcome Effect Vaccination effectiveness Michiels et al 12" exact="Vaccination" post="(TIV): n = 77 in 2002–2003; n = 100"/>
   <result pre="SII = seasonal influenza infection. TIV = trivalent influenza vaccination." exact="Vaccination" post="No studies were found that directly tested the impact"/>
   <result pre="10.1177/003335491012500206 20297744 29. Baron G De Wals P Milord F" exact="Vaccination" post="practices of Quebec family physicians. Influenza vaccination status and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC6986839/results/search/medproc/results.xml">
   <result pre="epidemiologist in the Division of Viral Diseases, National Center for" exact="Immunization" post="and Respiratory Diseases, Centers for Disease Control and Prevention."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7003341/results/search/medproc/results.xml">
   <result pre="therapy, including nasal catheter, mask oxygen, high flow nasal oxygen" exact="therapy" post="(HFNO), non-invasive ventilation (NIV) or invasive mechanical ventilation (Strong"/>
   <result pre="ventilation (NIV) or invasive mechanical ventilation (Strong recommendation). First, oxygen" exact="therapy" post="is the choice for patients with severe respiratory infections,"/>
   <result pre="NIV can be selected when nasal cannula or mask oxygen" exact="therapy" post="was ineffective or the patient had hypoxic respiratory failure."/>
   <result pre="of antivirals is still controversial [ 31– 34]. 6.3.2 Antibiotic" exact="therapy" post="Principles. Avoid blind or inappropriate use of antibacterial drugs,"/>
   <result pre="treatment in severe patients should cover all possible pathogens, deescalating" exact="therapy" post="until the pathogenic bacteria are clarified. 6.3.3 Corticosteroid therapy"/>
   <result pre="deescalating therapy until the pathogenic bacteria are clarified. 6.3.3 Corticosteroid" exact="therapy" post="The use of corticosteroids for severe ARDS is controversial;"/>
   <result pre="of hospital stay [ 35, 36]. Be cautious that hormone" exact="therapy" post="has some incidence of adverse reactions [ 37]. 6.3.4"/>
   <result pre="some incidence of adverse reactions [ 37]. 6.3.4 Other medications" exact="Symptomatic treatment" post="of fever. When the temperature is higher than 38.5 ℃,"/>
   <result pre="organ function. Hypoxic respiratory failure and severe ARDS. Give oxygen" exact="therapy" post="immediately to patients with ARDS, and closely monitor them"/>
   <result pre="respiratory failure. Consider severe hypoxemic respiratory failure when standard oxygen" exact="therapy" post="fails. When patients have increased frequency of breathing (&amp;gt; 30"/>
   <result pre="oxygenation. But NIV guidelines recommend the use of respiratory support" exact="therapy" post="in hypoxemic respiratory failure or pandemic viral illness. Limited"/>
   <result pre="treatment of patients with severe refractory hypoxemia in whom standard" exact="therapy" post="are failing; Routine use of high-frequency oscillatory ventilation (HFOV)"/>
   <result pre="harmful. However, HFOV may still be regarded as a rescue" exact="therapy" post="for patients with severe ARDS and refractory hypoxemia. ECMO"/>
   <result pre="temperature closely. 8.2 Nursing the patients 8.2.1 Nursing of oxygen" exact="therapy" post="Mild patients generally use a nasal catheter and a"/>
   <result pre="monitor the patient’s breathing and blood oxygen saturation. If oxygen" exact="therapy" post="fails to reach the expected effect, the nurse should"/>
   <result pre="Sequential oxygen care The critically illed patients mainly use oxygen" exact="therapy" post="such as HFNO, NIV and invasive mechanical ventilation. When"/>
   <result pre="therapies DIC Disseminated intravascular coagulation ECLS Extracorporeal life support ECMO" exact="Extracorporeal membrane oxygenation" post="ESR Erythrocyte sedimentation rate GRADE Grading of Recommendations Assessment,"/>
   <result pre="Recommendations Assessment, Development and Evaluation HFNO High flow nasal oxygen" exact="therapy" post="HFOV High-frequency oscillatory ventilation HRCT High-resolution computed tomography ICU"/>
   <result pre="work. We also thank Hao Chen’s help, the college of" exact="Acupuncture" post="and Chinese Tuina, Nanjing University of Chinese Medicine. Authors’"/>
   <result pre="syndrome: the impact of high dosage and duration of methylprednisolone" exact="therapy" post="Zhonghua Neike Zazhi 2004 43 3 179 182 15059370"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7004396/results/search/medproc/results.xml">
   <result pre="seasonal influenza with vaccines: recommendations of the Advisory Committee on" exact="Immunization" post="Practices—United States, 2019–20 influenza season. MMWR Recomm Rep 2019;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7021916/results/search/medproc/results.xml">
   <result pre="role in measles control. 12 Although the Expanded Program of" exact="Immunization" post="(EPI) in Egypt has achieved several successes in controlling"/>
   <result pre="rash. Table 2 Knowledge of HCWs Regarding Measles Infection and" exact="Vaccination" post="Variables* (The Correct Answer) Frequency (n=104) % Measles is"/>
   <result pre="3 Attitude and Practice of HCWs Regarding Measles Infection and" exact="Vaccination" post="(N=104) Questions Agree/Done No % Do you advise the"/>
   <result pre="(p&amp;lt;0.05). Table 4 Regression Analysis for Predicting Factors Affecting Measles" exact="Vaccination" post="Among the Investigated HCWs Variables OR (95% CI) Age"/>
   <result pre="Teleb N . A national survey to evaluate Measles-Rubella National" exact="Vaccination" post="Campaign Coverage in Egypt . J High Inst Public"/>
   <result pre="3): 343– 355. doi: 10.21608/ejom.2017.3925 18. collab: WHO. High-Quality Supplementary" exact="Immunization" post="Activities for Injectable Vaccines. Using an Example of Measles"/>
   <result pre="62( 2): 166– 172. doi: 10.1093/cid/civ802 26354971 26. collab: Who." exact="Immunization" post="of healthcare workers; 2019 Available from: https://www.who.int/immunization/policy/immunization_tables/en/. Accessed 7"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7073423/results/search/medproc/results.xml">
   <result pre="for latent TB infection (LTBI) with the TST, and preventive" exact="therapy" post="has been provided for those scored positive. In the"/>
   <result pre="al. Prolonged infectiousness of tuberculosis patients in a directly observed" exact="therapy" post="short-course program with standardized therapy . Clin Infect Dis"/>
   <result pre="patients in a directly observed therapy short-course program with standardized" exact="therapy" post=". Clin Infect Dis 2010; 51: 371– 378. doi:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7079436/results/search/medproc/results.xml">
   <result pre="• To assess the need for intubation prior to transport." exact="Intubation" post="is best done in ICU under controlled settings with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7079862/results/search/medproc/results.xml">
   <result pre="the need for data regarding supportive care and adjunctive pharmacologic" exact="therapy" post="that is specific for critically ill patients with severe"/>
   <result pre="users. Keywords Acute respiratory distress syndrome Influenza Neuraminidase inhibitor Antiviral" exact="therapy" post="Coronavirus Antiviral therapy Take-home message Evidence-based supportive care is"/>
   <result pre="respiratory distress syndrome Influenza Neuraminidase inhibitor Antiviral therapy Coronavirus Antiviral" exact="therapy" post="Take-home message Evidence-based supportive care is the mainstay for"/>
   <result pre="herpes simplex viruses, are not discussed in this review. Antiviral" exact="therapy" post="Generally available antiviral agents for different RVIs are summarized"/>
   <result pre="RCT of hospitalized patients with influenza ( n = 107), early combination" exact="therapy" post="with clarithromycin, naproxen, and oseltamivir was associated with reduced"/>
   <result pre="A(H1N1)pdm09 [ 23]. In patients with MERS ( n = 349), macrolide" exact="therapy" post="is not associated with a reduction in 90-day mortality"/>
   <result pre="of influenza [ 26]. The IDSA recommends against corticosteroid adjunctive" exact="therapy" post="in patients with influenza unless clinically indicated for other"/>
   <result pre="a study of patients hospitalized with RSV ( n = 50), corticosteroid" exact="therapy" post="was not associated with significant differences in peak viral"/>
   <result pre="16 non-ICU SARS patients, &quot;early&quot; (&amp;lt; 7 days of illness) hydrocortisone" exact="therapy" post="was associated with a higher subsequent plasma viral load"/>
   <result pre="28]. In a study on MERS patients ( n = 309), corticosteroid" exact="therapy" post="was not associated with significant change in 90-day mortality"/>
   <result pre="the putative anti-inflammatory effects, statins have been proposed as adjunctive" exact="therapy" post="in influenza (NCT02056340), although large clinical trials in patients"/>
   <result pre="would be beneficial in targeted subphenotypes of severe RVI. Immune" exact="therapy" post="Studies in which various antibody immunotherapies have been added"/>
   <result pre="are awaited, and data on severe RVI are needed. Antibacterial" exact="therapy" post="Co-infections with bacterial pathogens occur often with RVI. Co-infection"/>
   <result pre="The recent 2019 ATS/IDSA clinical practice guidelines recommend standard antibacterial" exact="therapy" post="to be initially prescribed for adults with community-acquired pneumonia"/>
   <result pre="10]. The guidelines provide details on when to consider empiric" exact="therapy" post="for methicillin resistant Staphylococcus aureus and Pseudomonas aeruginosa and"/>
   <result pre="and Pseudomonas aeruginosa and provide guidance for de-escalation of antibacterial" exact="therapy" post="in patients with confirmed influenza [ 10]. Clinicians should"/>
   <result pre="influenza A(H1N1)pdm09 influenza, HFOV has been used as a rescue" exact="therapy" post="for those not responding to conventional ventilation [ 53]."/>
   <result pre="in ARDS, there may still be a role as rescue" exact="therapy" post="[ 53]. Prone positioning A multicenter RCT ( n = 474,"/>
   <result pre="Specific data on neuromuscular blockade in severe RVI are lacking." exact="Extracorporeal membrane oxygenation" post="(ECMO) The latest RCT for ECMO (EOLIA) included 249"/>
   <result pre="the need for data regarding supportive care and adjunctive pharmacologic" exact="therapy" post="that is specific for critically ill patients with severe"/>
   <result pre="FG Fowler RA collab: Saudi Critical Care Trial G Corticosteroid" exact="therapy" post="for critically ill patients with middle east respiratory syndrome"/>
   <result pre="J Serra J Masclans JR collab: Investigators C High-flow nasal" exact="therapy" post="in adults with severe acute respiratory infection: a cohort"/>
   <result pre="Brodie D Mercat A collab: Eolia Trial Group R, Ecmonet" exact="Extracorporeal membrane oxygenation" post="for severe acute respiratory distress syndrome N Engl J"/>
   <result pre="Fan E Juni P Brodie D Slutsky AS Combes A" exact="Extracorporeal membrane oxygenation" post="for severe acute respiratory distress syndrome and posterior probability"/>
   <result pre="Lewis K Badawee M Arabi YM Fan E Alhazzani W" exact="Extracorporeal membrane oxygenation" post="for severe Middle East respiratory syndrome coronavirus Ann Intensive"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7079903/results/search/medproc/results.xml">
   <result pre="and evaluation stages. Treatment If the diagnosis is uncertain, empirical" exact="therapy" post="for community-acquired pneumonia should be considered using antibiotics with"/>
   <result pre="respiratory pathogens. In all series of SARS described to date" exact="therapy" post="has included broad spectrum antibiotics, including a fluoroquinolone or"/>
   <result pre="follow, as of 11 April 2003, is as follows: Antibiotic" exact="therapy" post="Respiratory fluoroquinolone or macrolide Ribavirin 400 mg intravenously every"/>
   <result pre="[ 8] to 2 mg/kg per day (similar to late-phase" exact="therapy" post="for acute respiratory distress syndrome) [ 7] to pulse"/>
   <result pre="increased risk of droplet transmission of virus by certain procedures." exact="Oxygen therapy" post="using aerosol humidifiers may increase the risk of droplet"/>
   <result pre="risk of droplet transmission of virus by certain procedures. Oxygen" exact="therapy" post="using aerosol humidifiers may increase the risk of droplet"/>
   <result pre="Difficult to seal at face Limit as much as possible" exact="Intubation" post="Coughing, agitation Sedation and neuromuscular blockade Suctioning Coughing, aerosolization"/>
   <result pre="of the use of noninvasive ventilation. Nebulized humidification for oxygen" exact="therapy" post="may carry similar risks, and our practice is to"/>
   <result pre="the expiratory port. High-risk procedures include endotracheal intubation and bronchoscopy." exact="Intubation" post="should be performed by the most skilled person available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7079951/results/search/medproc/results.xml">
   <result pre="on the practice of IR. Keywords Severe acute respiratory syndrome" exact="Interventional radiology" post="Infection control Aseptic techniques have traditionally been practiced in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7079971/results/search/medproc/results.xml">
   <result pre="7–15 days [ 4, 6, 7]; 5–22% require renal replacement" exact="therapy" post="[ 5, 6], and 28-day ICU mortality is 14–40%"/>
   <result pre="be performed at the bedside whenever possible Ensure safe respiratory" exact="therapy" post="practices to avoid aerosols Provide safe respiratory equipment (i.e.,"/>
   <result pre="arterial blood gases, bloods Oxygen regulators and clock Vacuum clock" exact="Electrocardiography" post="cables and leads Electrodes Gowns: sterile and nonsterile Nasal"/>
   <result pre="important equipment that may not be present in every hospital" exact="Extracorporeal membrane oxygenation" post="(ECMO) Pumpless extracorporeal lung assist (pECLA) High-frequency jet ventilator"/>
   <result pre="Unwitnessed cardiac arrest Witnessed cardiac arrest, not responsive to electrical" exact="therapy" post="(defibrillation or pacing) Recurrent cardiac arrest A second cardiac"/>
   <result pre="following return of spontaneous circulation and stabilization following successful electrical" exact="therapy" post="for initial malignant arrhythmia D. Severe baseline cognitive impairment"/>
   <result pre="on the ward and receive palliative care with active medical" exact="therapy" post="at the discretion of the primary care physician with"/>
   <result pre="high risk for disease transmission Aerosol humidification Bag-mask ventilation Bronchoscopy" exact="Cardiopulmonary resuscitation" post="Disconnection of endotracheal or tracheal tube from ventilator Extubation"/>
   <result pre="of endotracheal or tracheal tube from ventilator Extubation High-flow oxygen" exact="therapy" post="High-frequency oscillatory ventilation Intubation Mechanical ventilation without HEPA filter"/>
   <result pre="tube from ventilator Extubation High-flow oxygen therapy High-frequency oscillatory ventilation" exact="Intubation" post="Mechanical ventilation without HEPA filter on exhaust port Nasopharyngeal"/>
   <result pre="filter on exhaust port Nasopharyngeal swabs Nasotracheal or orotracheal suctioning" exact="Nebulization" post="of medications Noninvasive positive pressure ventilation Surgical airway HEPA"/>
   <result pre="suctioning and attention to pressure sites are a minimum requirement." exact="Palliative care" post="and monitoring of noninvasive and mechanical ventilation should be"/>
   <result pre="New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators (2009)" exact="Extracorporeal membrane oxygenation" post="for 2009 influenza A (H1N1) acute respiratory distress syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7080064/results/search/medproc/results.xml">
   <result pre="lopinavir/ritonavir or remdesivir effective against the SARS-Cov-2 infection? Does corticosteroid" exact="therapy" post="improve lung injury in viral pneumonia? What is the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7085817/results/search/medproc/results.xml">
   <result pre="respiratory failure: Recommendations: NIV may be used over conventional oxygen" exact="therapy" post="in mild early acute hypoxemic respiratory failure (P/F ratio"/>
   <result pre="for respiratory distress post extubation: Recommendations: We recommend that NIV" exact="therapy" post="should not be used to manage respiratory distress post-extubation"/>
   <result pre="with AECOPD without acidosis, comparing use of NIV plus standard" exact="therapy" post="versus standard treatment alone showed poor tolerance of NIV"/>
   <result pre="use. 75 Recommendations NIV may be used over conventional oxygen" exact="therapy" post="in mild early acute hypoxemic respiratory failure (P/F ratio&amp;lt;"/>
   <result pre="respiratory failure. 106 Use of high flow nasal cannula (HFNC)" exact="therapy" post="was compared with intermittent NIV. It did not result"/>
   <result pre="(2005) in their multicentre randomized controlled trial compared standard medical" exact="therapy" post="versus immediate post-extubation NIV use in selected high-risk population"/>
   <result pre="conventional weaning on invasive ventilation, extubation followed by standard oxygen" exact="therapy" post="and extubation to NIV. They found that weaning failure"/>
   <result pre="to standard medical therapy. 221 Recommendations We recommend that NIV" exact="therapy" post="should not be used to manage respiratory distress post-extubation"/>
   <result pre="3018 missions, in which there were 106 cases of NIV" exact="therapy" post="during the retrieval revealed that none of these patients"/>
   <result pre="&amp;gt; 10mm in size, which fall out within 1 metre." exact="Oxygen therapy" post="did not increase the droplet count in any size"/>
   <result pre="10mm in size, which fall out within 1 metre. Oxygen" exact="therapy" post="did not increase the droplet count in any size"/>
   <result pre="Aerosol Delivery Use of aerosol is an integral part of" exact="therapy" post="in COPD, asthma. Aerosol delivery is affected by leaks,"/>
   <result pre="treatment of patients with established post-extubation respiratory failure. Recommendations NIV" exact="therapy" post="should be initiated for patients in Critically Monitored Area"/>
   <result pre="S. Comparison of noninvasive positive pressure ventilation with standard medical" exact="therapy" post="in hypercapnic acute respiratory failure. Chest 1998 114 1636"/>
   <result pre="A Bayram N. Comparison of non-invasive ventilation and standard medical" exact="therapy" post="in acute hypercapnic respiratory failure: a randomised controlled study"/>
   <result pre="Noninvasive positive pressure ventilation vs invasive mechanical ventilation as first-line" exact="therapy" post="for acute hypoxemic respiratory failure in cancer patients. J"/>
   <result pre="Faucher E et al. Effect of Noninvasive ventilation vs oxygen" exact="therapy" post="on mortality among immunocompromised patients with acute respiratory failure:"/>
   <result pre="Agarwal R Khan A Aggarwal AN Gupta D. Bronchoscopic Lung" exact="Biopsy" post="Using Noninvasive Ventilatory Support: Case Series and Review of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7088200/results/search/medproc/results.xml">
   <result pre="in the hospital setting [ 12]. The Advisory Committee on" exact="Immunization" post="Practices (ACIP) recommends that vaccination efforts should focus initially"/>
   <result pre="Control Practices Advisory Committee (HICPAC) and the Advisory Committee on" exact="Immunization" post="Practices (ACIP) MMWR Recomm Rep 2006 55 RR-2 1"/>
   <result pre="(H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP), 2009 MMWR Morb Mortal Wkly Rep 2009"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7089121/results/search/medproc/results.xml">
   <result pre="a First symptoms (FS) Typical symptoms (TS), Lethality (L) Antibiotic" exact="therapy" post="(AT), Specific prophylaxis (SP), Infection control (IC) Facts and"/>
   <result pre="(IP), First Symptoms (FS) Typical symptoms (TS), Lethality (L) Antibiotic" exact="therapy" post="(AT), Specific prophylaxis (SP), Infection Control Data and comments"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7090434/results/search/medproc/results.xml">
   <result pre="could induce or exacerbate pulmonary complications in parturients with COVID-19)." exact="General anesthesia" post="was an option for cases of maternal or fetal"/>
   <result pre="(Table 1). Table 1 Demographic data ( n = 17)" exact="Epidural" post="anesthesia ( n = 14) General anesthesia ( n"/>
   <result pre="( n = 17) Epidural anesthesia ( n = 14)" exact="General anesthesia" post="( n = 3) Age, yr 29.5 (3.1) 28.7"/>
   <result pre="(Table 2). Table 2 Clinical characteristics ( n = 17)" exact="Epidural" post="anesthesia ( n = 14) General anesthesia ( n"/>
   <result pre="( n = 17) Epidural anesthesia ( n = 14)" exact="General anesthesia" post="( n = 3) Epidemiological exposure to SARS-CoV-2, n"/>
   <result pre="Table 3 Anesthesia management and surgery ( n = 17)" exact="Epidural" post="anesthesia ( n = 14) General anesthesia ( n"/>
   <result pre="( n = 17) Epidural anesthesia ( n = 14)" exact="General anesthesia" post="( n = 3) Method of delivery Elective Cesarean"/>
   <result pre="anesthesia group. Table 4 Neonatal outcomes ( n = 17)" exact="Epidural" post="anesthesia ( n = 14) General anesthesia ( n"/>
   <result pre="( n = 17) Epidural anesthesia ( n = 14)" exact="General anesthesia" post="( n = 3) Neonatal death, n (%) 0"/>
   <result pre="ground-glass opacities on chest CT scans and laboratory-confirmed SARS-CoV-2 positivity." exact="Epidural" post="or general anesthesia was safe and effective for surgical"/>
   <result pre="that the circulatory system is highly susceptible to SARS-CoV-2 infection." exact="General anesthesia" post="was used in three of our SARS-CoV-2-infected parturients. General"/>
   <result pre="General anesthesia was used in three of our SARS-CoV-2-infected parturients." exact="General anesthesia" post="did not have any adverse effects on the neonatal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7090449/results/search/medproc/results.xml">
   <result pre="open airway suctioning, patient coughing) as far as possible. 33" exact="Regional anesthesia" post="is preferred over general anesthesia. Awake intubation techniques should"/>
   <result pre="recover within the OR itself. Considerations specific to individual disciplines" exact="Interventional radiology" post="(IR) As far as possible, portable cases that can"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7090637/results/search/medproc/results.xml">
   <result pre="T et al. Exhaled air dispersion during high-flow nasal cannula" exact="therapy" post="versus CPAP via different masks Eur Respir J 2019"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7090728/results/search/medproc/results.xml">
   <result pre="fever (50%) and cough (38%). All patients recovered with symptomatic" exact="therapy" post="and there were no deaths. One case of severe"/>
   <result pre="extra corporeal membrane oxygen support may be needed. Renal replacement" exact="therapy" post="may be needed in some. Antibiotics and antifungals are"/>
   <result pre="advocate against their use, Chinese guidelines do recommend short term" exact="therapy" post="with low-to-moderate dose corticosteroids in COVID-19 ARDS [ 24,"/>
   <result pre="4%, extracorporeal membrane oxygenation (ECMO) in 3%, continuous renal replacement" exact="therapy" post="(CRRT) in 9%, antibiotics in 71%, antifungals in 15%,"/>
   <result pre="71%, antifungals in 15%, glucocorticoids in 19% and intravenous immunoglobulin" exact="therapy" post="in 27% [ 15]. Antiviral therapy consisting of oseltamivir,"/>
   <result pre="19% and intravenous immunoglobulin therapy in 27% [ 15]. Antiviral" exact="therapy" post="consisting of oseltamivir, ganciclovir and lopinavir-ritonavir was given to"/>
   <result pre="needed before these drugs are recommended. Other drugs proposed for" exact="therapy" post="are arbidol (an antiviral drug available in Russia and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7091034/results/search/medproc/results.xml">
   <result pre="under with Oseltamivir-resistant influenza A (H1N1) virus infection [ 23]." exact="Combination therapy" post="is also being evaluated for treatment of severe influenza"/>
   <result pre="with Oseltamivir-resistant influenza A (H1N1) virus infection [ 23]. Combination" exact="therapy" post="is also being evaluated for treatment of severe influenza"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7091420/results/search/medproc/results.xml">
   <result pre="HFNC should be limited to patients in appropriate airborne isolation." exact="Nebulization" post="of medications should also be avoided, particularly outside of"/>
   <result pre="outside of appropriate airborne/droplet isolation. Airway management and ventilatory support" exact="Intubation" post="of critically ill patients with SARS-CoV was associated with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7091695/results/search/medproc/results.xml">
   <result pre="the past 20 years. Some are highly contagious and fatal." exact="Vaccination" post="may not be available and antiviral drugs are not"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7093859/results/search/medproc/results.xml">
   <result pre="NA X Discontinue precautions only when the patient receiving effective" exact="therapy" post="is improving clinically and has three consecutive sputum smears"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7093872/results/search/medproc/results.xml">
   <result pre="to include patients who do not respond to appropriate antibiotic" exact="therapy" post="for atypical pneumonia caused by conventional agents (such as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094241/results/search/medproc/results.xml">
   <result pre="latter which is a target for the class of antiviral" exact="therapy" post="referred to as neuraminidase inhibitors. 1, 2, 18, 22,"/>
   <result pre="of infection control or other critical interventions. Clinical Testing Chest" exact="Radiography" post="Any patient presenting with shortness of breath or other"/>
   <result pre="on the Internet]. 2004 Jul [date cited]. Available from: http://www.cdc.gov/ncidod/ElD/vol10no7/04-0415.htm" exact="Computed tomography" post="(CT) scans were obtained from three of the five"/>
   <result pre="General Management Avian influenza patients can deteriorate rapidly. Initiating antiviral" exact="therapy" post="as soon as possible, along with airway management and"/>
   <result pre="day for at least 7 days. 20, 22, 25, 30" exact="Vaccination" post="against seasonal influenza is recommended if the HCW has"/>
   <result pre="risks, benefits, and likely outcomes of such practices. Vaccine Strategies" exact="Vaccination" post="remains one of the most effective ways to reduce"/>
   <result pre="containment a Early diagnosis b Rapid initiation of appropriate antiviral" exact="therapy" post="4, 11 i Oseltamivir ii Zanamivir 3 Strengthen early"/>
   <result pre="of cases and clusters a This may depend on you" exact="diagnosing" post="a community index case 5 Building general capacity for"/>
   <result pre="and preventive measures to patients, especially annual influenza vaccines. Whether" exact="diagnosing" post="the index case in the United States or being"/>
   <result pre="12 Sidwell R.W. Smee D.F. Peramivir (BCX-1812, RWJ-270201): potential new" exact="therapy" post="for influenza: Expert Opinion Invest Drug 11 2002 859"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094244/results/search/medproc/results.xml">
   <result pre="long as the COVID-19 resource centre remains active. Abstract Antiviral" exact="therapy" post="and vaccination are important strategies for controlling pandemic 2009"/>
   <result pre="management approach, is recommended when treating adult patients with ARDS." exact="Extracorporeal membrane oxygenation" post="has emerged as an important rescue therapy for critically"/>
   <result pre="ARDS. Extracorporeal membrane oxygenation has emerged as an important rescue" exact="therapy" post="for critically ill patients. Use of systemic steroids was"/>
   <result pre="the 1918 pandemic. 45 Convalescent plasma was used as rescue" exact="therapy" post="with seemingly favorable response in a 31-year-old male patient"/>
   <result pre="staff working while experience symptoms, and SARS patients requiring oxygen" exact="therapy" post="or NPPV, whereas availability of washing or changing facilities"/>
   <result pre="occurs within 0.4-m and 1-m radius of patients receiving oxygen" exact="therapy" post="via Hudson mask and during application of NPPV, respectively."/>
   <result pre="their efficacy is limited by timing of administration and supply." exact="Oxygen therapy" post="and NPPV should be applied in health-care facilities with"/>
   <result pre="efficacy is limited by timing of administration and supply. Oxygen" exact="therapy" post="and NPPV should be applied in health-care facilities with"/>
   <result pre="and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators" exact="Extracorporeal membrane oxygenation" post="for 2009 influenza A(H1N1) acute respiratory distress syndrome JAMA"/>
   <result pre="AP Webb A Ooi EE Webby RJ Passive immunoprophylaxis and" exact="therapy" post="with humanized monoclonal antibody specific for influenza A H5"/>
   <result pre="326 5953 2009 729 733 19745114 74 National Center for" exact="Immunization" post="and Respiratory Diseases CDC; Centers for Disease Control and"/>
   <result pre="(H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on" exact="Immunization" post="Practices (ACIP), 2009 MMWR Recomm Rep 58 RR–10 2009"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094372/results/search/medproc/results.xml">
   <result pre="Guangzhou and Hong Kong has identified SARS patients requiring oxygen" exact="therapy" post="and NPPV as independent risk factors for superspreading nosocomial"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094461/results/search/medproc/results.xml">
   <result pre="observation before the SARS treatment protocol with ribavirin and corticosteroid" exact="therapy" post="was instituted. † Data were collected during the hospitalization"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094516/results/search/medproc/results.xml">
   <result pre="regarding treatment. 8 Further influenza-specific testing should be considered. Antiviral" exact="therapy" post="and infection control measures should be undertaken regardless of"/>
   <result pre="health conditions, patients with renal impairment, or on renal replacement" exact="therapy" post="and pregnant women. Older patients (&amp;gt;65 yr) appear less"/>
   <result pre="for pandemic (H1N1) 2009 influenza. 63 Pandemic (H1N1) 2009 influenza" exact="Vaccination" post="Vaccination is one of the most effective ways of"/>
   <result pre="pandemic (H1N1) 2009 influenza. 63 Pandemic (H1N1) 2009 influenza Vaccination" exact="Vaccination" post="is one of the most effective ways of reducing"/>
   <result pre="initially recognized. Clinicians therefore need to also consider empirical antimicrobial" exact="therapy" post="for community-acquired pneumonia. 82 The ANZAC study reported 48.8%"/>
   <result pre="Moderate hypotension is often seen which is responsive to fluid" exact="therapy" post="and vasopressors. Caution should be exercised with volume expansion"/>
   <result pre="Michigan case series. 31 50 74 The need for vasopressor" exact="therapy" post="was often associated with the requirement for high sedative"/>
   <result pre="(DH) Letter from Director of Immunisation: The H1N1 Swine Flu" exact="Vaccination" post="Programme 2009–2010 Available from http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_106299.pdf (accessed October 11, 2009)"/>
   <result pre="October 23, 2009) 29 Department of Health (DH) Swine Flu" exact="Vaccination" post="Programme Available from http://www.dh.gov.uk/swinefluvaccinationprogramme (accessed October 11, 2009) 30"/>
   <result pre="2009) 30 Department of Health (DH) The H1N1 Swine Flu" exact="Vaccination" post="Programme 2009–2010 Available from http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_106299.pdf (accessed October 25, 2009)"/>
   <result pre="The Australia and New Zealand Extracorporeal Membrane Oxygenation Influenza Investigators" exact="Extracorporeal membrane oxygenation" post="for 2009 influenza A (H1N1) acute respiratory distress syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094533/results/search/medproc/results.xml">
   <result pre="by respiratory failure. Key words dispersion exhaled air influenza oxygen" exact="therapy" post="severe acute respiratory syndrome Abbreviations CAP, community-acquired pneumonia HPS,"/>
   <result pre="viral pneumonia, there is a potential risk that the respiratory" exact="therapy" post="itself may generate and disperse infective aerosols, resulting in"/>
   <result pre="our influenza pandemic preparedness, we studied the safety of oxygen" exact="therapy" post="by examining exhaled air dispersion from a simple oxygen"/>
   <result pre="Guangzhou and Hong Kong has identified SARS patients requiring oxygen" exact="therapy" post="or NPPV as independent risk factors for superspreading nosocomial"/>
   <result pre="NPPV. Few studies have assessed the potential risk of oxygen" exact="therapy" post="in spreading respiratory infection. Using an aerosolized 3% hypertonic"/>
   <result pre="the evaporation of water content in some droplets during oxygen" exact="therapy" post="may produce droplet nuclei that are suspended in air,"/>
   <result pre="to examine the dispersion of exhaled air from common respiratory" exact="therapy" post="devices in relation to the air exchange rate and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094662/results/search/medproc/results.xml">
   <result pre="joint infections resulting from a bronchoscopy procedure. However, prophylactic antibiotic" exact="therapy" post="should be considered for patients at high risk for"/>
   <result pre="at: Accessed September 22, 2004 90 Prakash UBS Prophylactic antibacterial" exact="therapy" post="for bronchoscopy: indications J Bronchol 4 1997 281 285"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7094700/results/search/medproc/results.xml">
   <result pre="benefit from tracheostomy after a few weeks of tracheal intubation." exact="Tracheal intubation" post="and tracheostomy are aerosol-generating procedures which may facilitate transmission"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7095295/results/search/medproc/results.xml">
   <result pre="COVID-19 patient or any patient who poses an infection risk." exact="Regional anesthesia" post="has benefits of preservation of respiratory function, avoidance of"/>
   <result pre="us to obtain CO 2 tracing and monitor respiratory movements." exact="Oxygen therapy" post="was identified as an independent risk factor for super-spreading"/>
   <result pre="to obtain CO 2 tracing and monitor respiratory movements. Oxygen" exact="therapy" post="was identified as an independent risk factor for super-spreading"/>
   <result pre="Caputo KM Byrick R Chapman MG Orser BJ Orser BA" exact="Intubation" post="of SARS patients: infection and perspectives of healthcare workers"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7096726/results/search/medproc/results.xml">
   <result pre="facilitate phlebotomy and provide intravenous access for medications and fluids." exact="Intubation" post="is performed using rapid sequence induction to reduce the"/>
   <result pre="considerations and planning to provide dialysis or continuous renal replacement" exact="therapy" post="(CRRT) is essential. 23 In regard to renal replacement,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7099308/results/search/medproc/results.xml">
   <result pre="of infection prevention interventions. Epidemic Potential and the Role of" exact="Vaccination" post="The epidemic potential of a pathogen is always a"/>
   <result pre="health vaccination campaigns and/or natural immunity for some infectious agents." exact="Vaccination" post="is very effective for controlling several infections of historical"/>
   <result pre="proper burial practices Mumps 4–7 Droplet, direct, and indirect contact" exact="Vaccination" post="and droplet precautions Polio 5–7 Direct and indirect contact"/>
   <result pre="Vaccination and droplet precautions Polio 5–7 Direct and indirect contact" exact="Vaccination" post="and enhanced environmental cleaning Smallpox 5–7 Airborne and contact"/>
   <result pre="Vaccination and enhanced environmental cleaning Smallpox 5–7 Airborne and contact" exact="Vaccination" post="and airborne and contact isolation Tuberculosis [ 19] a"/>
   <result pre="Chow AL Lye DC et al. Effects of early oseltamivir" exact="therapy" post="on viral shedding in 2009 pandemic influenza A (H1N1)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="./PMC7100231/results/search/medproc/results.xml">
   <result pre="on his back. He was hospitalised, isolated and administered supportive" exact="therapy" post="under barrier nursing. His condition deteriorated as he developed"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
